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Abstract
Arterial pulse wave analysis studies the wave shape of the blood pressure pulse.
The pulse wave provides more information than the extreme systolic and dia-
stolic pressures, measured with a cuff sphygmomanometer. The aim of the
research is to investigate the design issues in a pulse wave analysis system,
and to compare these to a commercially available system. The system was
compared and validated by measuring the pulse wave at the radial artery
(wrist) using the non-invasive technique of arterial tonometry. The design
conformed to the IEC-601 safety standard to ensure patient safety. The data
was compared against the data from the commercial system and analysis was
performed in the time and frequency domain. The performance of the design
suggests that, in some respects, the design was comparable to the commer-
cial system, however, a number of performance characteristics fell short of the
commercial system. Suggestions have been made to address these problems in
further research.
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Chapter 1
Introduction
1.1 Introduction
Pulse wave analysis (PWA) is the study of the waveform of the blood pressure
pulse. The arterial pulse is the most fundamental sign in clinical medicine and
has been studied for over 100 years [1]. Traditional blood pressure measure-
ments are recorded using a cuff sphygmomanometer, which only measures the
extremes of the brachial artery pressure; i.e. the systolic and diastolic values [1].
Much more information can be retrieved by analysing the full time-dependent
pulse wave shape. This allows physicians to give an improved diagnosis of
cardiovascular diseases.
The pulse pressure can be measured internally (invasive) or externally (non-
invasive). This research is based on non-invasive measurements. By focusing
on the non-invasive measurements, readings can be acquired easily and with
little medical knowledge. There are various techniques for non-invasive meas-
urements of the pulse wave shape. These include arterial tonometry, Doppler
ultrasound and photoplethysmography and are explained in Section 2.4. The
method used for this research is arterial tonometry.
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1.2 Problem Statement
Pulse wave analysis is an expanding field of research which has developed
rapidly over the last decade. There have been many papers written about
PWA which approach the topic with different objectives. The first approach
is to study the wave shape using a particular measuring technique, normally
tonometric methods, and relate PWA to arterial diseases. The second approach
is to measure the pulse contour using a number of measuring techniques and
to compare the validity of these techniques.
In the studies that compared measuring techniques, comparisons have been
made between two or more different techniques. Mustafa and Feneley [2]
and van Lieshout et al [3] have compared Doppler and photoplethysmography,
Oliver and Webb [4] have compared photoplethysmography and arterial tono-
metry, and Brinton et al [5] have compared oscillometric methods with intra-
arterial catheter recordings.
In disease related research, the pulse was measured using only one method.
Cruickshank et al [6] used Doppler ultrasound and Hlimonenko et al [7] studied
PWA using photoplethysmography. The majority of studies [8, 9, 10, 11, 12, 13,
14, 15, 16] have used arterial tonometry. Amongst these studies only Asmar et
al [16] used a different pressure transducer (TY-306, Fukuda Co). The rest all
used the Sphygmocor system (Atcor Medical, Australia), which incorporates
the SPT-301 micromanometer by Millar Instruments.
The problem is that there have been few studies where different arterial tono-
metry systems have been compared against each other. Most researchers use
the Sphygmocor system because it is commercially available and is easy to use.
This has led to Sphygmocor dominating the arterial tonometry sector. There
are other arterial tonometry systems such as the Colin CBM-7000, (ScanMed
17
Medical Instruments, UK) but these have been studied [17] and have been
found unsuitable for intensive care use. The aim of the research is to invest-
igate the design issues in a pulse wave analysis system, and to compare these
to the Sphygmocor System.
1.3 Research Methods
The approach to the research consisted of two parts. The first was to build a
device to measure the pulse wave shape. The system needed to be electrically
safe to ensure patient safety. Arterial pulse signals have a small voltage range,
so sufficient amplification and filtering was needed. Chapter 3 details the
hardware design.
The second part of the research involved recording the pulse wave shape of dif-
ferent test subjects using the designed system and the commercial Sphygmocor
system. The results from the designed system were compared and validated
against the results from the Sphygmocor system.
Tests were conducted in the physiology labs at Wits Medical School. Ethics
approval was required before any test on human subjects could commence.
The device was electrically tested to ensure patient safety. The device must
conform to IEC 601-1, which is the safety standard for medical equipment [18].
1.4 Specifications and Limitations
The designed system will be in direct contact with the patient’s body while
measuring the pulse and Electrocardiogram. The equipment will also be con-
nected to a mains supply via the computer and data acquisition system (DAQ).
It is therefore essential that the appropriate safety standards are maintained
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to avoid the risk of electrical shock. For medical electrical equipment the
standard is the SABS IEC 60601-1 (or IEC 601-1) - Part1: General
requirements for safety [18].
According to this standard the device is classified as Class I type BF equip-
ment. The relevant electrical specifications for such a device are defined as
follows:
• The designed device is classed as INTERNALLY POWERED EQUIP-
MENT, however, because of its connection with the DAQ and computer
it must comply to the requirements for Class I equipment.
• Class I equipment is required to have double or reinforced insulation.
In the case where basic insulation is provided (such as a computer) a
separate earth conductor is required.
• The patient auxiliary current and patient leakage current must not ex-
ceed 10µA under normal DC conditions and 50µA under a single fault
condition.
• The earth leakage current must not be greater than 0.5mA under normal
conditions.
The above specifications must be adhered to in order to maintain patient safety.
The testing methods and results to ensure that these standards are met are
presented in Section 3.7.
1.5 Structure of Report
The dissertation is split into several chapters. These include:
19
• Pulse Wave Analysis Background: This chapter explains the the-
ory behind Pulse Wave Analysis (PWA), the benefits, and the previous
studies of PWA. The purpose of the chapter is to give the reader a better
understanding of PWA.
• Hardware Design: The majority of the work went into designing the
device that was tested. This section describes the different sections of
the circuit. The requirements for medical devices are presented. An
explanation as to how these requirements are met in the design is given.
• Testing and Analysis Procedure: The device needed to be tested
to determine its capabilities. This chapter consists of two parts: the
first part explains the testing procedure. It includes the ethical require-
ments, hardware constraints and limitations of the test procedure. The
second part explains the analysis of the results. This will explain what
algorithms were applied to the results and why.
• Test Results: The results of the signal analysis are explained in this
chapter. Possible explanations are given for the results, as well as possible
conclusions. A discussion of the results is included.
• Conclusion: A discussion on the feasibility of developing a PWA system
and the associated costs is presented
20
Chapter 2
Background of Pulse Wave
Analysis
2.1 Overview
This chapter provides some insight into pulse wave analysis and its relation
to arterial diseases. The shape of the arterial pulse wave is an augmentation
of the forward traveling wave with the reflected wave. The amount of wave
reflection is dependent on the arterial wall properties such as arterial stiffness
and is expressed in terms of Augmentation Index. A mathematical transfer
function has been used to estimate the waveform of the aortic artery for further
assessment of arterial deseases. This approach has been studied extensively
using various measuring techniques, all of which have respective advantages
and disadvantages. The purpose of PWA can be seen in the section describing
the medical conditions that affect the wave shape (Section 2.5). Although the
medical relationships are not examined in this research, a discussion is included
to assist the reader in understanding the purpose of pulse wave analysis. An
explanation into the origins of pulse wave analysis is provided in Appendix A.
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2.2 Description of Pulse Wave Shape
O’Rourke [19] describes the pulse wave shape as:
“A sharp upstroke, straight rise to the first systolic peak, a defin-
ite sharp incisura, and near-exponential pressure decay in the late
diastole.”
This definition is explained further [20, 21]:
Arteries are compliant structures, which buffer the pressure change resulting
from the pumping action of the heart. The arteries function by expanding and
absorbing energy during systole (contraction of the cardiac muscle) and release
this energy by recoiling during diastole (relaxation of the cardiac muscle). This
function produces a smooth pulse wave comprising a sharp rise and gradual
decay of the wave as seen in Figure 2.1. As the arteries age, they become less
compliant and do not buffer the pressure change to the full extent. This results
in an increase in systolic pressure and a decrease in diastolic pressure.
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Figure 2.1: Example of pulse wave shape
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An artery exhibits the properties of a transmission line and as such can be
modeled to have an input impedance and a characteristic impedance. In a
network of vessels the input impedance is a ratio of pressure to flow, and can
be described by a complex number Z¯i(ω). The magnitude of Z¯i(ω), which is
expressed in Equation 2.1 is the amplitude ratio of pressure and flow [22].
∣∣∣Z¯i(ω)∣∣∣ =
∣∣∣∣∣ P¯i(ω)Q¯i(ω)
∣∣∣∣∣ (2.1)
The characteristic impedance is defined as the input impedance of an infin-
itely long straight tube with constant properties. In this case the input im-
pedance will be independent of position and dependent only on vessel and
fluid properties. The magnitude of the characteristic Impedance Z0 is given
by Equation 2.2 [22].
|Z0| =
ρc
A
(2.2)
where A = the cross-sectional area of the vessel, c = wave propagation velocity
and ρ = blood density.
The characteristic impedance can be used to determine the size of the reflected
wave. These wave reflections occur at points where the properties of the ar-
teries change, and hence the characteristic impedance changes, such as a split
in the arterial path.
The velocity of the wave propagation c is affected by the elasticity of the
artery and is approximated by the Moens-Korteweg relationship given in Equa-
tion 2.3 [21, 22].
c =
√
Eh
2ρr
(2.3)
where E = wall elastic modulus, h = wall thickness, ρ = blood density and
r = vessel radius.
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2.2.1 Wave Reflection
In an arterial system, the input impedance of the vessel varies with changes
in the vessel’s size and properties. For compliant arteries, which have more
elasticity, the wave propagation velocity would be small (Moens-Korteweg Re-
lationship) and hence the Characteristic Impedance would be lower. In rigid
arteries the propagation velocity is greater, resulting in a higher impedance.
This change in impedance will affect the Reflection Coefficient [22].
Wave reflections occur at arterial junctions where the input impedances of
a parent and daughter vessel do not match. The reflection is expressed in
terms of a Reflection Coefficient R. The Reflection Coefficient is a ratio of the
reflected wave amplitude to the incident wave amplitude and is related to the
relative characteristic impedance of the vessels at the junction. In the case
where a vessel splits from a primary artery into two branches with different
impedances the Reflection Coefficient is given by Equation 2.4 [22].
R =
Z−10 − (Z
−1
1 + Z
−1
2 )
Z−10 + (Z
−1
1 + Z
−1
2 )
(2.4)
where Z0 is the characteristic impedance of the primary artery and Z1 and Z2
are the characteristic impedances of the branched arteries.
The reflection coefficient at each branch point for the arterial system is usually
less than 0.2, however, as these coefficients accumulate the overall reflection be-
comes much greater [22]. The reflected wave augments with the incident wave
to produce the characteristic wave shape, which is shown in Figure 2.1. This
augmentation produces additional load on the heart, which is characterised by
the augmentation index (AiX) [23].
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2.2.2 Augmentation Index
The Augmentation Index (AiX) is a measure of the amount of reflection the
pressure wave experiences. This reflection translates into additional load on
the left ventricle. AiX is the difference between the second peak and the first
Systolic peak (As shown in Figure 2.1) as a percentage of ascending aortic
pulse pressure (Equation 2.5) [23].
AiX =
second peak − first peak
systolic pressure − diastolic pressure
× 100 (2.5)
AiX depends upon heart rate, Pulse Wave Velocity (PWV) and the amplitude
of the reflected pulse [23]. In a younger patient, whose arteries are more
compliant, the PWV is slower, so the reflected wave arrives at the heart after
the aortic valve has closed. In such a case the additional load on the heart is
small or absent. In older subjects, where the arteries are stiffer, the PWV is
much higher. This results in the reflected wave arriving at the heart before
the aortic valve closes, and creates additional load on the heart.
The AiX is calculated from the central aortic pulse wave shape [8, 23]. Meas-
uring the aortic pulse is a complex process and can only be performed using
invasive methods. This problem is solved by applying a transfer function to
a measured peripheral wave, such as the radial, femoral or the carotid artery.
Commercial devices, such as the Sphygmocor system, use a generalised transfer
function to calculate the aortic wave shape [19].
2.2.3 Aortic Pulse Estimation
The aortic waveform is generated from the radial or carotid artery using a
generalised transfer function. This process can be seen in Figure 2.2. This
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approach is used in the Sphygmocor VX (Atcor Medical, Sydney, Australia)
and assumes one function for the arterial system for any condition [1]. This
is of concern since the arterial system changes with age, therapy and various
arterial conditions. Even with these differences, O’Rourke’s research [1] shows
that this approach is successful with more than 90% accuracy (athough the
author does not define this accuracy).
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Figure 2.2: Radial to aortic estimation. (a) measured pulse from radial artery
using the Sphygmocor system; (b) aortic pulse estimated by a transfer function
on the Sphygmocor system.
The problem with this approach is the validation of the transfer function.
Segers et al [13] showed that the generalised transfer function led to discrep-
ancies between the synthetic pulse contour and the measured pulse contour.
Their study used transmission line theory to develop a transfer function that
can be individualised by changing the patients characteristics (age, blood pres-
sure, etc). This approach used a model that was too simple and their results
showed that it was not possible to calculate an individualised function.
Millasseau et al [10] determined that the transfer function neither added nor
subtracted information contained in the radial pulse. They concluded that the
transfer function is of limited value in estimating the effect of central arterial
wave reflection, and the same information could be obtained directly from
the radial pulse. The developers of the Sphygmocor system responded to this
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Figure 2.3: An electrocardiograph illustrating the QRS complex
study by saying that the comparisons were limited [24].
2.3 Electrocardiogram
An Electrocardiogram (ECG) was developed for use as a timing signal. This
section will touch on an explanation of the ECG, and show how it is associated
with the arterial pulse.
The electrocardiograph is a recording of the electrical activity generated by
the heart, measured on the body’s surface. The ECG is the measured voltage
difference between the active (depolarised) area and the inactive (polarised)
area of the heart. The waveform is made up of five deflections (sometimes six).
These deflections, when present, are designated by the letters P, Q, R, S, T,
and U. An example of an ECG wave, measured using a Lead I configuration,
can be seen in Figure 2.3. Waves P, R, T and U are usually positive (peaks),
while waves Q and S are usually negative (troughs) [20].
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The most important feature of the ECG for the present study is the QRS com-
plex. This represents the depolarisation of the ventricles [20]. The QRS com-
plex is used as the timing /gating mark for the pulse contours. This allows
the pulse contour to be recorded at different sites separately and aligning the
contours together using the ECG signal. This method is the approach used
in the Sphygmocor system [19] in order to calculate pulse wave velocity, and
eliminates the need to record the pulse contour at two sites simultaneously,
which has proved to be difficult [25, 26].
2.4 Measurement Techniques
Pulse wave analysis requires accurate recordings of the arterial pulse. There
are two approaches for measuring the wave shape of the arterial pulse, viz -
invasive and non-invasive assessment. Invasive techniques involve measuring
the wave shape with the use of arterial catheters. This method is generally only
used in high-care or intensive care settings where the operator has extensive
medical experience. Non-invasive readings are easier to retrieve as they can be
performed outside of a hospital and do not involve any needles or injections.
Measurements are taken from the surface of the skin, using various techniques.
The most popular non-invasive techniques, which are explained in detail in the
subsequent sections, are:
• Arterial Tonometry,
• Photoplesymography,
• Doppler Ultrasound,
• Korotkoff Sounds,
• Oscillometry.
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Korotkoff sounds and oscillometry only measure the systolic and diastolic pres-
sures and not the full pulse wave.
2.4.1 Arterial Tonometry
Arterial tonometry is based on the method of applanation tonometry, which
was originally used to measure the pressure on the retina of the eye. Arterial
tonometry is performed by placing a transducer over the artery and depressing
the sensor to ”applanate” (flatten) the artery. The sensor would have to be
re-positioned until a clear pulse is detected. Once the sensor has been posi-
tioned the operator applies pressure and the pulse wave shape is recorded. The
amount of applied pressure needs to be carefully determined. If the artery is
not flattened sufficiently the sensor will measure the forces of the arterial wall
tension and the bending of the artery, and if too much pressure is applied, the
sensor would occlude the blood flow [22]. Arterial tonometry provides a record-
ing of the full pulse profile, however, it does not provide a calibrated pressure.
The waveform is subsequently calibrated to the blood pressure, measured with
a cuff sphygmomanometer [1, 22].
Most of the studies that use arterial tonometry make use of a piezoresistive
pressure sensor to measure the pulse. Other methods such as using Bragg
grating sensors in an optical fibre have been studied [27]. The present research
uses piezoresistive pressure sensors for pulse measurement. Arterial tonometry
has been used in studies for synthesis of the aortic pulse [1, 2, 19], studies into
reproducibility of the pulse wave shape [8, 23] and in studies where the validity
of the transfer function has been examined [10, 13].
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2.4.2 Photoplethysmography
Photoplethysmography uses optical methods (infra-red) to measure the volu-
metric pulsations of the blood flow [22]. This method is generally applied to
the finger, and is most commonly used in pulse oximetry. Very little attention
is paid to the waveform received from pulse oximetry [1]. Feneley et al [2] used
photoplethysmography as a comparison to arterial tonometry and to synthesise
the aortic pulse.
2.4.3 Doppler Ultrasound
Doppler ultrasound uses echo methods to record arterial volume. Van Lieshout et al [3]
conducted a study where the pulse wave shape recorded with ultrasound was
compared to photoplethysmography. They concluded that the Doppler ultra-
sound method requires skill and continuous attention to the direction of the
ultrasound beam, using audio and visual techniques.
2.4.4 Other Methods
Korotkoff sounds is an auscultatory method, whereby the pulse pressure is
determined by the sounds emitted distally from a partially occluded vessel [22].
This method makes use of an inflatable cuff, which is placed around the limb
and a stethoscope is placed on the skin overlying the artery just distal to the
cuff. The cuff is inflated to about 30 mmHg above the point where the sounds
cease. The cuff is slowly deflated until sounds can be heard, which change as
the pressure decreases. Initially a tapping sound can be heard, which denotes
the systolic pressure. As the cuff deflates even more the tapping sound becomes
a slight murmur, and eventually disappears altogether. The pressure at which
the sound disappears denotes the diastolic pressure. This is a common method
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which is used everyday for cuff sphygmomanometry.
Oscillometry works by compressing the artery with a cuff, and observing the
change in oscillations which are produced by the pressure pulse. These oscil-
lations are measured with the use of a pressure sensor, which is situated in
the cuff. As the cuff is slowly deflated the characteristics of the oscillations
change. It has been discovered that the point at which the oscillations are at
a maximum corresponds to the Mean Arterial Pressure (MAP). Systolic and
diastolic pressures are found where the oscillations are a fixed percentage of
the maximum oscillations [22]. This method is generally used in automated
devices.
2.5 Factors Affecting Pulse Wave Shape
The pulse wave shape changes according to physiological changes, medication,
disease and lifestyle habits. Although this research is not intended to invest-
igate these changes, an understanding of these factors is required in order to
appreciate the relevance of this work.
2.5.1 Physiological Factors
The pulse wave shape can be affected by different physiological conditions. A
few of these conditions are briefly explained [1]:
• Growth and development: In infants, the arterial pulse contour in
the central arteries is the same as the peripheral arteries. There is no
second wave in diastole. This is due to the short body length, which
causes the reflection wave to arrive sooner at the heart.
• Age: In older subjects, the second systolic peak starts to disappear.
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This is a result of increased arterial stiffness and hence an increase in
PWV. As the pulse increases in velocity the second peak appears closer
to the first systolic peak, eventually forming a contour with only one
distinct peak.
• Diet: Ingestion of food and drink can reduce wave reflection. This alters
the wave contour, and the degree of late systolic augmentation [1].
• Body Height: The augmentation is dependent on body height, regard-
less of age. In shorter subjects the augmentation is greater than that of
taller subjects.
• Gender: There has been a measured difference in pulse contour between
male and female populations. This could, however, be due to the differ-
ence in height.
2.5.2 Arterial Diseases
Pulse wave velocity has made a large contribution in studies of arterial diseases.
These diseases include, but not exclusive to:
• Arteriosclerosis: This refers to the thickening and stiffening of the
arterial wall [21]. As the arteries stiffen, the pulse wave velocity in-
creases. This results in early wave reflection at the junctions in the ar-
teries. The reflected wave reaches the incident wave quicker and produces
Late Systolic Pressure Augmentation, which can result in an increase of
40–50mmHg to systolic pressure in the central arteries [1].
• Hypertension: Hypertension is an abnormal increase in the systolic,
diastolic or mean arterial pressure, or all three. This is due to increased
arterial stiffness and can be monitored using PWA [1]
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• Diabetes Mellitus: Diabetes mellitus (Type I Diabetes and Type II
Diabetes) has been associated with an increase in arterial stiffness [1].
O’Rourke’s [1] studies showed that PWA does not aid in the diagnostics
of diabetes mellitus. Further research by Cruickshank [6] showed that
PWV is a powerful independent predictor of mortality for diabetes.
• Chronic Renal Failure: Savage et al [11] conducted an investigation
into the reproducibility of PWA on patients with Chronic Renal Failure
(CRF). Their study concluded that indices of arterial stiffness, such as
AiX and Time to Reflection (TR), which is determined by PWA, can
assist in the assessment of CRF.
2.6 Summary
The study of the pulse contour can provide important information, which
cannot be determined from only the systolic and diastolic pressures. The
different methods of recording the contours have been discussed, with emphasis
placed on arterial tonometry, as this is the method used in the present research.
Existing studies have shown the importance of the parameters determined by
PWA. Certain parameters rely on the use of a transfer function to determine
the aortic pulse contour.
33
Chapter 3
Hardware
3.1 Overview
The procedure undertaken in the present research was to build a measuring
device using arterial tonometry, which can be used for pulse wave analysis. The
radial pulse of the test subject was recorded using this device and compared
to the pulse contour recorded from the Sphygmocor system.
The designed system comprises two sub-systems: The arterial tonometric sys-
tem and the electrocardiogram system, which are presented in Sections 3.2.1
and 3.2.2 respectively. The system was powered by two 9 Volt batteries, which
were electrically isolated from one another. One battery powered the patient
side of the circuit while the other battery powered the amplification side. The
designed system was tested for compliance against IEC 601–1, the safety stand-
ard for medical equipment [18].
To record high quality biological signals, biopotential systems need to satisfy
some basic requirements [22]. These include:
• The monitored signal (such as the pressure pulse or the ECG) should
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not be influenced by the measurement system,
• The signal must not be distorted by the measurement system,
• The system must offer protection to the subject against any electrical
hazard,
• The system must successfully separate the desired signal from the noise
and interference.
A data acquisition system (DAQ), based upon the ADSP-21061 Digital Signal
Processor (DSP) from Analog Devices was used to capture the signals. The
amplified pulse and ECG signals are sampled at 1Khz with a 16 bit resolution.
The DSP controls the communication with the computer using a USB connec-
tion. Matlab and Simulink are used to visualise and store the pulse and ECG
signals.
This chapter covers the design of each of the stages of the electrical design.
The design of the amplification, filtering, isolation and detection sections are
explained. The complete circuit diagrams are shown in Figure B.8 and B.9 on
page 94 and 95 respectively. The circuits are explained in more detail in the
Appendix B.
3.2 Design Overview
3.2.1 Arterial Tonometry Design
The arterial tonometry system measures the pulse wave shape by recording
the deflection of the skin caused by the pulse pressure. The system made
use of a highly sensitive pressure transducer, and necessary amplification and
filtering techniques, which are shown in the block diagram in Figure 3.1. The
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Figure 3.1: Block diagram of arterial tonometry system
tonometry system was housed in two plastic enclosures: One contained the
sensor and the sensor amplification and the second enclosure contained the
electrical isolation and filtering. The circuit diagram for the sensor unit is
presented in Figure B.9 and the circuit diagram for the filtering and isolation
circuit is presented in Figure B.8, in Appendix B.
3.2.2 Electrocardiogram Design
The electrocardiogram is a bipolar, AC signal in the range of 0–10mv with
a bandwidth of 0.05Hz–150Hz. The ECG provides information over the full
range of frequencies. The lower frequencies provide a correct measurement for
the slower ST waves while at higher frequencies accurate information about
the QRS complex is contained. At this frequency range there are several
sources of noise. High frequency noise includes noise due to muscle contractions
and low frequency noise includes respiratory noise and baseline drift due to
body motion [22]. 50Hz noise was also introduced from surrounding electrical
equipment. Amplification and filtering needed to be carefully chosen to obtain
a good quality ECG waveform.
Figure 3.2 shows the block diagram of the ECG amplifier. The ECG was
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Figure 3.2: Block diagram of ECG amplifier
measured using the Einthoven’s 3-lead ECG configuration. A Lead is the con-
nection of two biopotential electrodes used to record an ECG [20]. The Lead
configurations are shown in Table 3.1. In this study the Lead I configura-
tion was used which connected the left arm (LA) (positive) and the right arm
(RA) (negative). Although other Lead configurations were tried, the Lead I
produced the best QRS complex, and it was easier and convenient to attach
the ECG electrodes to the arms. These two electrodes measured the voltage
difference across the heart (LA-RA), which is caused by polarisation and de-
polarisation. A third electrode was used as a reference point, which was taken
from the right leg. This electrode was connected to a circuit known as a right
leg drive, which uses a negative feedback loop to reduce the common-mode
interference [22]. The Right Leg driver circuit is explained in more detail in
Appendix B.2.2.
Lead Positive Electrode Negative Electrode
I Left Arm Right Arm
II Left Leg Right Arm
III Left Leg Left Arm
Table 3.1: Einthoven’s 3-Lead ECG configuration
The ECG amplifier was initially built on a dual supply system due to the
bipolar nature of the ECG signal. It was subsequently converted to a single
supply system to reduce the circuit complexity and to keep it in line with the
arterial tonometry system, which was single supply.
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3.2.3 Assembly
The majority of the circuit was housed in a plastic box of 120mm×76mm×42mm.
The sensor and its pre-amplifier were housed in a smaller box of 50mm×35mm×20mm.
The circuit was assembled on prototyping strip-board, which, in hind sight,
was a poor decision because the strip-board required additional debugging,
and delayed the testing process.
3.3 Signal Detection
Arterial tonometry measures the pulse waveform by recording the deflection of
the skin over an artery. This deflection is caused by the pressure pulse, which
can be recorded using highly accurate pressure transducers. The pressure
transducer is placed on the skin, over the artery, and by compressing the
artery slightly with the sensor, the pulse waveshape is recorded.
The pressure transducer used in the design is the IC-Sensor model 84 (IC
Sensor, MSI, USA). This is a piezoresistive pressure sensor, packaged in a
stainless steel housing. The pressure contact area has a diameter of 19.1mm,
and transfers pressure from the diaphragm to the sensor through silicon oil [28].
The transducer has a pressure range of 0–300mmHg, with a full scale output
span of 100mV, and zero pressure output of 1mV. The resolution of the sensor
is 0.33 mV/mmHg.
The pulse wave shape is measured by gently placing the transducer over the
radial artery, in the same way as one would do to feel a pulse. The size of
the contact surface therefore plays a big role in the measurement of the pulse.
The contact surface area of the Model 84 sensor is significantly larger than that
of the Millar micromanometer, which can be seen in Figure 3.3. The larger
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Figure 3.3: Comparison of different sensors. The top sensor is the IC-Sensor
enclosed in a plastic housing and the bottom sensor is the hand held probe
from Millar Instruments, which is used in the Sphygmocor system.
surface area did prove to have definite advantages and disadvantages.
The advantages of the Model 84 Sensor included: increased sensitivity, which
allowed smaller deflections to be measured without too much pressure being
applied to the artery. This also resulted in no visible pressure marks being left
on the wrist once the sensor was removed.
The disadvantage to the larger surface area was that it was clumsy to handle.
The Millar micromanometer is the size of a pen and is easy to hold steady
while recording was in progress. The larger sensor made it more difficult to
hold steady while recording the pulse. Another down side to the larger sensor
was the difficulty experienced while trying to find the pulse on subjects with
small wrists. In these cases the small bones in the wrist obstructed the site for
the pressure sensor.
The Millar micromanometer was used as a reference point as this has been the
preferred sensor to use in arterial tonometry research. The Model 84 pressure
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sensor was selected because it produced the best results in preliminary tests.
Other sensors which have been used for this purpose include the Motorola
MPX2300DT1 disposable medical sensor used by Salter and Bird [25], but
was not included due to its disposable nature. Current research conducted
by The Rand Afrikaans University (RAU), Johannesburg makes use of fibre
optics to measure the pulse [27].
3.4 Amplification
3.4.1 Pulse Amplification
The arterial blood pressure can range from Diastolic pressures of 50mmHg up
to Systolic pressures in excess of 200mmHg. Non-invasive pressure measure-
ments do not record the blood pressure directly but rather the deflection on
the skin caused by the arterial pulse wave. This measurement would not ex-
ceed 100mmHg, therefore the full scale of the pressure sensor was not required.
The measured pressure range required a minimum amplification of 100, which
was achieved using two stages of amplification.
An instrumentation amplifier was used to amplify the signal to a range of 0–5V.
The instrumentation amplifier used discrete components, i.e. three op-amps,
instead of using a single chip instrumentation amplifier. This method made
use of the internal gain set resistor of the pressure sensor. By using the gain
set resistor, the interchangeability of the sensor was maintained. However,
this approach meant that a single chip instrumentation amplifier (such as the
AD623 from Analog Devices) could not be used. In order to maintain a high
accuracy and avoid a DC voltage offset, 1% tolerance resistors and precision
op-amps were used. The design used Microchip MCP609 amplifiers which have
a Common Mode Rejection Ratio (CMRR) of 91dB and an input offset voltage
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of 250µV. The instrumentation amplifier provided a gain of 75, which resulted
in a pulse amplitude of approximatly 1.5V peak-to-peak. The circuit diagram
is shown in Appendix B.2, where it is explained in more detail.
The second stage of amplification was included after the instrumentation amp-
lifier. In order to measure a pulse using applanation a certain amount of pres-
sure must be applied to the artery in order to detect a pulse. This applied
pressure creates a DC offset, which can vary. This variation is caused by op-
erator movement, fluctuations between the pressure probe and the artery and
the condition of health of the test subject. To remove this offset, the signal
is filtered through a high-pass filter with a cut off frequency of 0.3Hz. The
output of the filter was the pulse wave shape, with the DC offset removed.
This signal was passed through a non-inverting amplifier with a variable gain
of between 1 and 10. The end result was a signal that the user could clearly see
on the screen, which assisted in recording the best signal. A similar variable
gain function is used in the Sphygmocor system, however it is implemented in
software and not hardware.
The block diagram in Figure 3.1 shows two outputs. Output 1 is the signal
with the applied pressure (i.e. the signal does not go through the high-pass
filter and second amplifier). This signal provides a direct measurement of the
pressure applied to the artery, which would be used in the analysis of the data.
The second output, Output 2, is the result of the second stage amplifier.
3.4.2 ECG Amplification
The electrocardiogram has a voltage range of between 0.1mV–10mV [22]. A
preamplifier with a high CMRR and a high input impedance was required for
the amplification of the ECG. This was achieved with the use of a AD623 single
chip instrumentation amplifier from Analog Devices. The AD623 features a
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CMRR of 100dB with a frequency response of 100KHz and is powered by a
single-ended power supply. Although Analog Devices recommends the AD620
instrumentation amplifier for an ECG application [29], the AD620 was tested
and it was found that the AD623 produced greater amplification with less
noise. The AD620 also required a dual supply system which created a problem
in the system which was primarily single supply. The instrumentation amplifier
provided a differential gain of 12.14 (see Appendix B.2).
A right leg driver circuit was used to provide a reference potential for the
ECG amplifier. The drive circuit amplified the common mode interference in
an inverting amplifier and fed the output back into the circuit as the reference
electrode. This inverted common mode voltage reduced the common mode
interference of the amplifier [22].
The signal was then filtered using a bandpass filter, which is explained in
Section 3.5. A second amplifier stage, which formed part of the bandpass
filter, was included in the design. A non-inverting amplifier with a gain of 40
was used. The overall gain of the ECG amplifier was 485. This produced an
output voltage range of 0–1.5V.
The full circuit diagram of the ECG amplification is presented and explained
in Appendix B.2.
3.5 Noise Reduction
A medical environment provides a number of sources for noise, but the majority
of noise is 50Hz line interference [22]. In the case of the arterial tonometry
system the main sources of noise are high frequency noise (> 200Hz) and 50Hz
line interference. The isolation amplifier reduced a lot of the high frequency
noise, but did not remove the 50Hz line interference. A fourth order, analogue,
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low-pass Butterworth filter with a -3dB point of 40Hz was used. This filter,
shown in Figure B.4 in Appendix B, reduced the 50Hz noise, but also reduced
the bandwidth of the pulse signal to 0–40Hz.
A high pass filter with a cut off frequency of 0.3Hz was included after the low
pass filter. This filter removed the DC offset which is caused by the constant
pressure applied to the wrist. This did cause a problem in that as soon as the
pressure was released the signal would saturate to ground, and then only after
a short period of time return to the reference point. The values for the RC
network were chosen to keep the time constant low, however, this did increase
the cut-off frequency.
The ECG potential suffers from the same noise problems as the arterial pulse as
well as additional noise. Noise is introduced by surrounding equipment as well
as biophysical interference caused by respiration or muscle contractions [22, 30].
A bandpass filter is used to attenuate high frequency noise as well as to remove
the DC offset and baseline drift [22]. The bandpass filter, which is presented
and explained in Appendix B.3, comprises a first order high pass filter (HPF)
with a cutoff frequency of 0.05Hz and a first order low pass filter (LPF) with
a cut-off frequency of 100Hz.
A Twin-T notch filter was used to attenuate the 50Hz line interference in the
ECG circuit. The filter comprises a first order high pass and first order low
pass filter whose frequencies are exactly matched to 50 Hz. The circuit diagram
and explanation can be found in Appendix B.3. The results of the notch filter
are evident in Figures 3.4 and 3.5, which show an ECG trace before and after
a notch filter was added.
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Figure 3.4: ECG trace without a notch filter
Figure 3.5: ECG trace with a notch filter
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3.6 Patient Safety and Isolation
Patient safety needed to be taken into consideration in the design of the pulse
amplifier and the ECG amplifier. This was achieved by focusing on two aspects,
namely by using a battery power supply and electrical isolation.
3.6.1 Electrical Isolation
Electrical isolation can be achieved with the use of isolation amplifiers. An
isolation amplifier is required to break ground loops and provide isolation pro-
tection to the patient and electronic equipment [22]. The main purpose of
the isolation amplifier is to protect the patient by eliminating the hazard of
electric shock, which could be caused by leakage currents flowing to ground
through the patient under a fault condition [18, 22]. Even though both the
ECG system and the arterial tonometry system were battery operated, the
system was connected to a computer and the DAQ system which were both
powered by a mains supply (230VAC). The isolation amplifiers were used to
safeguard the patient from any possibility of leakage currents caused by the
DAQ or computer.
Isolation amplifiers are defined by Isolation Mode Rejection Ratio (IMRR),
which is the ratio between the isolation voltage and the output voltage of the
amplifier. The typical value of IMRR for medical equipment is 140dB at DC
and 120dB at 60Hz, with an isolation impedance of 1.8pF‖1012Ω [22].
The design used opto-coupling isolation methods since the amplifiers are small,
easy to use and can transmit low frequencies [31]. Two different opto-coupling
isolation amplifiers were tested in the research. These are presented in Table 3.2
and the test results are explained.
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Table 3.2: Tested opto-isolation amplifiers
Isolation
Opto-Isolator Voltage (VISO) IMRR Impedance Ref
HCPL7800 3750 V >140 dB ≥ 1× 1012 [32]
4N28 3750 V Not Specified 1× 1012 [33]
The HCPL7800, which is a digital opto-coupler, was first tested in the circuit.
The signal was first digitised, and then transmitted from the patient side to
the circuit side using an optocoupler. The digital stream was converted back
to an analogue signal and outputted. This amplifier was tested and the output
signal was found to be extremely noisy. It was also found that a DC offset was
introduced in the output signal. In two different cases an offset of 600mV and
−250 mV were introduced.
The second isolation amplifier that was tested was the 4N28. This is simply a
matched photo diode and photo transistor. The 4N28 is defined by the Current
Transfer Ratio (CTR), which has a typical value of 100%. The current was
controlled by a resistor in series with the diode and by a resistor in series with
the emitter of the transistor. By varying the value of these resitors, the signals
were transmitted accross the isolation barrier without causing any saturation.
The circuit diagram and explanation are presented in Appendix B.4.
3.7 Testing and Calibration
3.7.1 Electrical Safety Compliance Test
The device needed to be tested and calibrated before use. The most important
test was the electrical safety. The device was classified by the IEC 601-1
standards as a Class I device and had to meet the specifications described in
Section 1.4.
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Electrical safety was tested with the use of a certified test-bed specifically
designed to test compliance of IEC 601-1 standard. The testing was conducted
by Brittan Health Care (Johannesburg, South Africa) and the results of these
tests can be found in Appendix D. The patient auxiliary current was checked
on all of the electrode leads as well as the contact surface of the pressure sensor.
In the case of the ECG, all the leads measured a patient auxiliary current of
less than 3µA at DC. The maximum limit is specified at 10µA [18].
The earth resistance of the full measurement system (computer, DAQ and
sensors) was tested according to IEC 601-1 standards. Even though the system
was powered by batteries there was still the possibility of the leakage currents
from the DAQ or computer finding a path to ground through the patient.
This problem was prevented with the use of the isolation amplifiers. The
earth resistance of the system was measured at 3Ω, well within the 200Ω
specification.
3.7.2 Sensor Calibration
The complete pulse amplification system was tested and calibrated to determ-
ine the linearity of the amplified signal. This was achieved by attaching a
modified cuff sphygmomanometer to the pressure sensor and measuring the
voltage output as the pressure increased. The manometer’s pressure was in-
creased in increments of 5mmHg ranging from 0mmHg to 110mmHg. The
voltage was recorded at the output of the Butterworth filter, and the results
can by seen in Figure 3.6. This calibration provided an indication of the pres-
sure that was applied to the wrist. It did not provide a calibration for the
pulse wave, which was performed in software instead.
Non Linearity =
Nˆ
OMAX −OMIN
× 100% (3.1)
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Figure 3.6: Calibration curve of system
The non-linearity of the system is calculated between 0 mmHg and 110 mmHg
by Equation 3.1 [34], where Nˆ is the maximum non-linearity and OMIN and
OMAX define the output range. The overall pulse system exhibits a non-
linearity of −11.43% between 0 and 110mmHg. The graph also exibits an error
between 0mmHg and 80mmHg, which is greatest around 20–40mmHg. This
error provided early indication that the design of the sensor may be flawed.
Since the curve shown in Figure 3.6 was not used to calibrate the pressure
pulse, the cause of this error and non-linearity was not invetigated further.
3.8 Data Acquisition
The data was captured and recorded onto a computer using a Data Acquisition
System (DAQ) which was developed at The University of the Witwatersrand,
Johannesburg. The DAQ is based on the ADSP-21061 Digital Signal Processor
(DSP) from Analog devices. The DAQ communicated with the computer via
Matlab and Simulink using software that had already been developed for data
acquisition, which received the data from the DSP through a USB connection.
Three signals were sampled using the DAQ system: One ECG signal and
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two pressure pulse signals (one filtered and one unfiltered). The signals were
sampled using an analogue-to-digital converter (ADC) with a 16-bit resolution
and at a sampling frequency of 1KHz. Offsets of 4 and 7 volts were added
to the unfiltered pulse and ECG respectively, using a Simulink model. These
offsets allowed the user to view all three pulses simultaneously without any of
the traces overlapping one another on the screen. The data was recorded in 10
seconds segments and stored in the Matlab workspace, where it was analysed
further.
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Chapter 4
Testing and Data Analysis
Methods
4.1 Overview
The signals retrieved from the designed arterial tonometry system were valid-
ated by testing the system on a small group of test subjects. The following
chapter explains the testing procedure, the ethics requirements and the meth-
ods used to analyse the data. Different approaches were used in the analysis
which have been explained and compared in this chapter. The results of the
tests are laid out in Chapter 5.
4.2 Measurement Procedure
The arterial tonometry device was tested by doing a comparative analysis on
nine test subjects. The subjects’ characteristics are detailed in Table 4.1. Sub-
ject 2 was discarded because there was a problem with recording the data. The
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testing was conducted at the School of Physiology, University of the Witwater-
srand, under the supervision of Professor Gavin Norton.
No. Sex Age Blood Pressure
(yrs) SBP(mmHg) DBP(mmHg)
1 M 30 130 78
2 F 26 122 80
3 M 54 134 90
4 M 33 130 82
5 M 25 120 78
6 F 28 118 76
7 M 36 124 82
8 M 63 250 92
9 F 45 114 76
Mean 38 138 82
STD 13 42 6
SBP = Systolic Blood Pressure
DBP = Diastolic Blood Pressure
Table 4.1: Subject characteristics and clinical results
The procedure for testing was as follows:
1. Record the subject’s blood pressure using a cuff sphygmomanometer,
2. Record the waveform of the radial artery using the Sphygmocor system,
3. Record the subject’s ECG using the designed system,
4. Record the waveform of the radial artery using the designed arterial
tonometry system.
The first two steps of the procedure were conducted by a trained operator who
has expert knowledge of the Sphygmocor system. The measurements using
the designed system were conducted by a different operator, who was more
familiar with the designed system.
The pulse waveform is measured in the same way as feeling for a pulse on the
wrist. The pressure sensor is placed on the wrist, over the radial artery. The
location of the sensor for each system can be seen in Figure 4.1.
51
The pulse wave shape was recorded for eight of the nine subjects. The data for
Subject 2 was discarded since a clear pulse wave shape could not be recorded.
The pulse wave shape was recorded for the remaining eight test subjects, how-
ever the quality of the recordings varied. The reasons for this variability have
been outlined in Section 5.2. An example of a recording is shown in Figure 4.2,
where it can be seen that the pulse from the Designed system saturate at zero
volts. This was caused by an insufficient DC offset. The full set of recorded
data from all nine subjects can be found in Appendix C.
Figure 4.1: Location of pressure transducers on the wrist; (a) designed system
and (b) Sphygmocor System
4.2.1 Ethics Approval
Before any tests could commence ethics approval was obtained from the Hu-
man Ethics Research Committee at The University of the Witwatersrand, Jo-
hannesburg. The code of ethics requires that the research is safe and ethical
and that the rights of the test subjects are respected. All the test subjects
were properly informed about the research and testing methods and testing
did not commence without their written consent. The information sheet and
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Figure 4.2: Ten second recording of pulse measured from both systems
consent form as well as the Certificate for Ethics Approval can be found in
Appendix 4.2.1.
4.3 Data Preparation
4.3.1 Signal Enhancement
The recordings of the pulse wave shapes were retrieved in intervals of 10
seconds, as shown in Figure 4.2. Any high frequency noise, which was not re-
moved by the analogue filters was removed before further analysis took place.
This was done with a digital infinite impulse response (IIR) Butterworth filter.
The filter was designed, using Matlab, with a 50Hz cutoff point and a roll off
of -60dB at 150Hz. To prevent any phase shift a zero phase shift filter was
used. The filter was applied to both the ECG signal and the pulse signal. Once
the high frequency noise was removed, the signal was divided into individual
pulses and calibrated to the pulse pressure.
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4.3.2 Pulse Wave Calibration
The data received by the Sphygmocor system was scaled differently to the data
from the designed arterial tonometry system. Data from both systems were
calibrated to the range of the pulse pressure. The pulse wave shape was scaled
to the pulse pressure but careful attention needed to be taken to prevent the
signal from distorting. In a single pulse recording the maximum peak can vary
even though the systolic pressure is constant. This variation is related to the
movement of the pressure sensor and not to the actual pulse pressure changing.
By measuring this variation the performance of the pressure transducer can be
measured. If the signal was distorted this measurement would be incorrect.
To avoid distortion, the pulse signal is calibrated with reference to the average
of all the individual pulses of a particular subject (i.e. a period of the wave-
form). Figure 4.3 shows the average pulse and the individual pulses where the
systolic peaks have not been distorted.
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Figure 4.3: The individual pulse periods calibrated with respect to the average
pulse
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The algorithm used to calibrate the waveform is as follows:
1. Remove the DC offset by subtracting the value of the foot of the pulse.
(Estimation of the foot of the pulse is explained in Section 4.4),
2. Scale the pulse by a ratio of pulse pressure to the mean value, i.e.
(× systolic pressure− diastolic pressure
max(avg pulse)−foot(avg pulse)
)
3. Shift the pulse by the value of the diastolic pressure.
4.4 Pulse Foot Identification
The recorded signals from both systems displayed some DC drift, which made
it difficult to analyse the complete pulse signal. Since the pressure pulse is
a periodic signal, as shown in Figure 4.2, the signal could be divided into its
individual pulses to assess the quality of the recording. This was performed
using three different methods. The starting point of the individual pulses
needed to be consistent to ensure that any time-domain comparisons were
accurate. If the location of the foot of the pulse varied for each pulse, the
systolic rise time and any subsequent time measurement would have been false.
There are four methods which have been used to identify the foot of each
pulse [35], these include:
1. The point of minimum diastolic pressure,
2. The point where dP/dt is a maximum (The sharp upstroke of the pulse
waveform),
3. The point where the second derivative is a maximum,
4. The point where the line tangent of the initial upstroke and the horizontal
line through the minimum point intersect.
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Chiu et al [35] concluded that method 3 and 4 yielded the best results for
invasive and non-invasive methods, with a correlation coefficient between data
of greater than 0.9. The approach taken for the present research was to test
methods 1 and 3 as well as an additional method of using the peak of the QRS
complex (defined in Section 2.3 on Page 27) of the ECG as the start of the
pulse period. The three different algorithms were tested on the pulse signals
to determine which method was the most efficient in identifying the individual
pulses. The different methods were compared by analysing the individual
pulses with respect to the mean value of the pulses. This was achieved using
three diagnostic measurements, which were:
• The time difference (τ) between the systolic peak of each pulse and the
systolic peak of the mean pulse. This was affected by the location of the
foot of the pulse. If the diastolic foot is consistent, the time difference
will be minimal.
• The Correlation Coefficient (CC) between each individual pulse.
• The Root Mean Square (RMS) error between the average pulse and each
individual pulse.
The results from the three different methods are presented in Chapter 5. The
algorithms for each method are described in the next three sections.
Method 1: Point of Minimum Diastolic Pressure
The method of finding the minimum diastolic pressure is as follows:
1. Determine the middle point of the systolic upstroke by finding the max-
imum of the first derivative dP/dt,
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tFigure 4.4: Time variation of Systolic peak
2. Identify the point of maximum dP/dt for each systolic upstroke by in-
creasing the range of the search criteria by 2 × standard deviation of
dP/dt
3. Using a search algorithm, find the first trough preceding each point of
maximum derivative. This point marks the foot of each pulse.
This method was the most successful for separating the wave into individual
pulse periods. Only one set of data out of nine sets could not be separated.
The disadvantage of this method was the large variation in the time between
each individual pulse (τ), which can be seen in Figure 4.4. Method 1 produced
the largest error for the time variance of the systolic peak (5.36 ± 22 ms). An
example of the results from method 1 can be seen in Figure 5.2 (a)
Method 2: Point of Maximum Second Derivative
Two different algorithms were used to determine the foot of the pulse by max-
imum d2P/dt2. The first attempt used a simple algorithm that determined the
maximum value of d2P/dt2 within a limited range. This algorithm had a poor
success rate of only 50% . The second attempt was more involved and had a
90% success rate. The successful algorithm is as follows:
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1. Determine the point of the maximum of the first derivative as explained
in the Method 1.
2. By working backwards along the curve of d2P/dt2, from the point of
maximum dP/dt, the maximum of d2P/dt2 is found
3. Identify all the pulse periods and separate the wave into individual pulses
as shown in Figure 5.2 (b).
The correlation between the individual pulses showed an improvement from
that of Method 1. The correlation coefficient (0.90 ± 0.09) correlates with
Chiu’s [35] findings for this method. The time variance of the systolic peaks
showed an improvement (−0.86 ± 17.5 ms), however the RMS error has in-
creased (11.3 ± 6.02 mmHg).
Method 3: Using the R wave of the ECG
This method makes use of the ECG signal that is recorded simultaneously.
The QRS complex of the ECG, which is generally much greater in amplitude,
is used as the timing mark. This provided a consistent point to mark the start
of each individual pulse, which can be seen in Figure 5.2 (c). This method
relies on a good quality ECG signal recording to successfully identify the start
of each pulse. This was not the case for two of the tests subjects who had
poor or irregular ECG recordings. The time variance (τ) showed only a slight
improvement on Method 2 (−0.67 ± 14.6 ms). The correlation coefficient and
RMS error were worse than those of Method 1 and Method 2.
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4.5 Performance Analysis
4.5.1 Pulse Wave Quality
A good quality signal is required for an accurate assessment of the arterial
system. The quality of the signal from the designed system was assessed
and compared with the quality of the Sphygmocor signal. The aim was to
determine the reproducibility of the waveshape using the designed system.
The quality of the full recording of 10 seconds is assessed by separating the
pulse signal into the individual pulses and comparing these to the average pulse.
The pulse signal from both systems are separated using the second derivative
method (method 2) as described in Section 4.4. This method was chosen
since it produced the best results for correlation coefficient and RMS Error
(Table 5.1) and it is the default method used by the Sphygmocor system [35].
An example of the individual pulses retrieved from the designed system and
the Sphygmocor system can be seen in Figure 4.5(c & d) respectively. The full
set of results can be found in Appendix C.1
This analysis was performed on the results from the designed system and the
Sphygmocor system. The results retrieved for the designed system are com-
pared against the results for the Sphygmocor system. In both cases the average
pulse for each system is taken as the point of reference, and is calculated by
Equation 4.1 [34],
y¯ =
1
N
i=N∑
i=1
yi (4.1)
where N is the number of pulses per ten second recording (N = 13 for Fig-
ure 4.5(a)) and yi are the sampled data points of the pulse.
The signal is assessed by comparing key points on each of the average pulses.
These points, which were used in the study by Fetics et al [36] to compare
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Figure 4.5: Example of recorded data: (a) pulse signal measured using de-
signed System; (b) pulse signal measured using Sphygmocor system; (c) sep-
arated pulse from designed system; (d) separated pulse from Sphygmocor
system; (e) Mean (solid line) and standard deviation (dashed line) of pulse
from designed system; (f) comparison of pulse of the designed system and the
Sphygmocor system
the radial artery wave shape with an estimated aortic artery wave shape, are
labeled in Figure 4.6 and are explained in the following paragraphs. They
include:
Error in Systolic Pressure
The error in the systolic pressure was calculated as the difference between the
peak of each pulse and the systolic blood pressure. The systolic blood pressure
was measured using the Sphygmomanometer.
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Error in Systolic Rise Time
The error in the systolic rise time provided an indication of the consistency of
the pulse foot. The error is calculated as the difference between the individual
pulse and the mean pulse.
Correlation Coefficient
The correlation coefficient provides a measure as to how close each pulse is
related to the next. For a good quality signal each pulse must be as closely
related as possible to the next and should be above 90% correlation [37]. The
correlation coefficient , r, between signal x and y is obtained from
r =
∑n
i=1(xi − x¯)(yi − y¯)√∑n
i=1(xi − x¯)
2
√∑n
i=1(yi − y¯)
2
(4.2)
where x¯ and y¯ are the mean values calculated using Equation 4.1.
Root-Mean-Square Error
The Root-Mean-Square (RMS) error was calculated for each pulse with respect
to the mean pulse. The equation for RMS error is given in Equation 4.3 [38].
To test the signal quality the Actual value is equal to the mean value. This
results in the RMS error being equivalent to the standard deviation of the
pulse. An example of the standard deviation (RMS error) of a single pulse
can be seen in Figure 4.5(e). To avoid confusion in the following chapters, the
notation for the RMS error is RMSstd.
ErrorRMS =
√∑
(Actual − Predicted)2
Number of Predictions
(4.3)
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The results of the quality tests are expressed as mean ± SD, and are presented
in Chapter 5.
4.5.2 Sphygmocor Comparison
The second test was to compare the signal between the Sphygmocor and the
designed system. Unfortunately the large fluctuations in the recordings preven-
ted any meaningful comparisons between the full 10 second recordings meas-
ured form the two systems. The cause of these fluctuations are described in
Section 5.2. Due to the high variability of the recordings from the designed sys-
tem, all the comparisons were performed using the average of the pulses from
both systems, calculated using Equation 4.1. The data from the Sphygmocor
was interpolated from 128Hz to 1000Hz in order to match the sampling fre-
quency of the designed system. A FFT interpolation algorithm was used for
this purpose.
The aim of this test was to compare the readings of the designed device with
that of the Sphygmocor system. The problem arose that even though the
Sphygmocor system is the leading system in this field of measurement its
weakness is in its validation [1]. Several studies [1, 8, 10] have been performed
to determine the reproducibility of the the pulse wave velocity and the aug-
mentation index and the validation of the transfer function as calculated by the
Sphygmocor system. With no set standard and reference point for this type
of measurement, the Sphygmocor was assumed to be a true point of reference.
The pulse signals from the two systems were compared by analysing three
points on the curve as well as the RMS error between the two pulses [36].
The three points, as seen on Figure 4.6, were the systolic peak, the second
systolic peak and the dicrotic notch. An example of the comparisons is shown
in Figure 4.5(f). The result of the comparisons are discussed in Chapter 5,
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and the full set of results can be found in Appendix C.
Systolic Peak
The most common measurement for blood pressure is the systolic and diastolic
pressures. If the systolic peak is not recorded correctly, or is distorted by the
measuring system this would result in an incorrect assessment of the pulse rate
and blood pressure.
The error in systolic pressure is calculated as the difference between the mean
pulse and the systolic pressure measured from the Sphygmomanometer. The
error in the rise time is calculated as the difference between the designed system
signal and the Sphygmocor signal.
Second Systolic Peak
The second systolic peak is due to the reflection caused by a change in the
artery’s impedance [21, 22]. Assessment of the wave reflection is useful in
determining the Augmentation index, pulse wave velocity and arterial stiff-
ness [1]. It is important that the second peak is not distorted in any way as
this would provide an incorrect assessment for the patient.
The error in time and pressure is calculated as the difference between the
designed system and the Sphygmocor system.
Dicrotic Notch
The dicrotic notch, as shown in Figure 4.6 is also used as a measured for
arterial diseases when analysed together with the second systolic peak [4, 21].
Once again, the dicrotic notch cannot be distorted by the measuring system.
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Figure 4.6: Parameters for comparison of the wave shapes
The error in pressure and time is calculated in the same way as the second
systolic peak.
Root-Mean-Square Error
The RMS error is calculated using Equation 4.3, where Predicted is the de-
signed system data and Actual is the Sphygmocor data.
4.5.3 Frequency Analysis
Fast Fourier Transform
An analysis of the frequency spectrum was performed to determine the fre-
quency harmonics of both systems. The analysis was performed by applying
a Fast Fourier Transform (FFT) to both systems. The FFT algorithm used
a 32768 point Discreet Fourier transform (DFT) algorithm with a Hanning
Window.
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The frequency response analysis provided information about the main fre-
quency components as well as a measure of how much the signal is distorted
by the measurement system [38].
The frequency harmonics were analysed by comparing the normalised FFT
of both systems [38]. A normalised FFT was used since only the ratio of
the frequency harmonics was being investigated so the actual value was of
little importance. An example of the FFT of both systems can be seen in
Figure 4.7 (a–c). The FFT of the designed system and the Sphygmocor system
are shown in Figures 4.7 (a) and (b) respectively. The comparison of the FFT
for both systems is shown in Figure 4.7 (c). The results of the FFT for all the
test subjects can be found in Appendix C.4.
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Figure 4.7: Example of the comparison of the frequency spectrum. (a) Fre-
quency spectrum of the designed system; (b) Frequency spectrum of the
Sphygmocor system; (c) Comparison of the frequency spectrum between two
systems
65
2.9 2.95 3 3.05 3.1 3.15 3.2
0.5
1
1.5
2
2.5
Time (sec)
M
ag
ni
tu
de
 (V
olt
s)
Figure 4.8: Impulse response of the designed system.
Impulse Response of the Designed System
A model of the designed system was calculated by estimating a Laplace transfer
function (H(s)). The transfer function was calculated using convolution of the
impulse response [38]. A simple test was set up to simulate an impulse, and
measure the response.
In the impulse response set-up the pressure transducer was placed on a solid
surface and held firmly. A short, sharp strike to the transducer with a pen
simulated an impulse. The impulse response was measured at the output of
the Butterworth filter (Output 1 of Figure 3.1 on Page 36). Figure 4.8 shows
the recorded impulse response. This test set up only worked for the designed
system. Unfortunately due to limitations in hardware and software an impulse
could not be recorded from the Sphygmocor system. Analysis and discussion
of the impulse is presented in Chapter 5.
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Chapter 5
Test Results
5.1 Overview
This chapter presents the results of the comparisons and tests as described in
Chapter 4. The measurement procedures of the two systems are compared and
discussed. The results of the testing methods outlined in the previous chapter
are presented. This includes determining the foot of the pulse, assessment
of the pulse signal, comparison of the two systems and an assessment of the
frequency spectrum. The analysis of the impulse response is included in an
effort to model the transfer function of the designed system.
5.2 Comparison of Testing Procedures
The procedure to record the pulse wave using the designed system was more
complicated than the Sphygmocor system. During testing, the pulse wave
shape was retrieved easily and quickly, and with better quality using the
Sphygmocor system than the pulse retrieved from the designed system. This
was ascribed to several factors.
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• The size of the pressure transducer. The smaller pressure transducer of
the Sphygmocor system made it easier to find the pulse. The pulse was
difficult to measure using the larger transducer particularly in the case
of the female tests subjects with small wrists.
• Physical design of the pressure transducer. The Sphygmocor incorpor-
ates a pen like transducer. This was easy to hold and keep steady while
recording the pulse. The designed system’s transducer was in a small
rectangular box which was clumsy and difficult to hold.
• The operator / physician. A steady hand was required to measure the
pulse accurately and acquire a good quality signal. The Sphygmocor
operator has been trained to identify and measure the pulse wave using
the Sphygmocor system, and she has extensive experience in PWA. This
experience, and having a steady hand has led to her recording good
quality signals. The operator of the designed system could not always
retrieve a good quality signal due to the lack of experience in identifying
and measuring the pressure pulse. This inexperience also made it difficult
to keep the transducer steady.
• As previously mentioned, two different operators, with different levels
of experience, were used for the different systems. This inconsistency
resulted in the high variability of the results measured from the designed
system.
• The Sphygmocor incorporated some filtering and preprocessing into the
system which assists with pulse identification. The lack of filtering in
software for the designed system meant that the pulse signal was not
always clearly identified.
These problems did not prevent the pulse from being recorded properly. Al-
though there were difficulties in measuring the pulse using the designed system,
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Figure 5.1: Comparison of pulse quality. (a) Poor quality pulse; (b) Good
quality pulse
good quality, ten second pulse trains were recorded in three of the tests sub-
jects. For the remaining test subjects only a portion of the full ten second
recordings were used for further analysis. A poor quality signal and a good
quality signal are shown in Figure 5.1(a) and Figure 5.1(b) respectively. Time
permitting, more experience in performing the measurements could be gained
and more readings could be recorded properly.
Both systems did not require a large amount of applied pressure. The ap-
plied pressure was measured on the designed system and was calibrated to the
curve in Figure 3.6 on page 48. The average applied pressure on the skin was
measured to be 35 mmHg. Patients reported no discomfort from either system
during and after the tests. Neither of the pressure transducers left any visible
pressure marks on the skin.
5.3 Results of Pulse Foot Identification
The pulse train was separated into individual pulses using three different meth-
ods. These methods are described in detail in Section 4.4. The different meth-
ods were compared using the diagnostic measurements: Time difference (τ),
Correlation Coefficient (CC) and Root Mean Square (RMS) error, which have
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Designed system
Measure Method 1 Method 2 Method 3
CC 0.90± 0.05 0.90± 0.09 0.86 ± 0.16
RMS Error 7.5± 6.02 11.3± 6.02 18.0± 16.0
(mmHg)
τ −5.36 ± 22.0 −0.86 ± 17.5 −0.67 ± 14.6
(msec)
Sphygmocor
Method 1 Method 2
CC 0.99 ± 0.006 0.99 ± 0.005
RMS Error 3.11 ± 3.60 3.80 ± 4.41
(mmHg)
τ −2.30 ± 5.23 −1.91 ± 5.38
(msec)
The ECG algorithm (Method 3) was not applied to the
Sphygmocor data.
Table 5.1: Results of methods to identify the foot of the pulse
been described in Section 4.4. The diagnostic measurements are represented
as Mean ± Standard Deviation. Table 5.1 provides a summary of the results
from the three different methods. The pulses retrieved from each method are
shown in Figure 5.2 (a–c) and a comparison can be seen in Figure 5.2 (d). The
full set of results can be found in Appendix C.2.
The location of the pulse foot was the most consistent when using the Second
derivative method (Method 2). All the pulse signals were prepared for further
analysis by separating the pulse using Method 2.
5.4 Quality of Pulse Wave Shape
The quality of each pulse signal was compared and the overall results are
summarised in Table 5.2, which are expressed as mean ± SD. The distribution
of the results are shown Figure 5.3(a–d).
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Figure 5.2: Results from the different methods of calculating the foot of the
pulse. (a) Method 1 result; (b) Method 2 result; (c) Method 3 result; (d) com-
parison of the mean pulses of the three methods.
Diagnostic Measure Designed Sphygmocor
System System
Error in Systolic 2.3 ± 18.9 0.10 ± 6.67
Pressure (mmHg)
Percentage Error in Systolic 1.3 ± 8.3 0.07 ± 3.36
Pressure (% mmHg)
Error, Pressure Rise Time −0.87 ± 17.5 −1.92 ± 5.4
(τ) (msec)
Correlation Coefficient 0.90 ± 0.09 0.99 ± 0.01
RMS error (mmHg) 11.35 ± 18.9 3.80 ± 4.41
(RMSstd)
Table 5.2: Assessment of quality of pulse wave recording
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Figure 5.3: Results of quality assessment (a) error in Systolic peak; (b) error
in systolic rise time; (c) correlation coefficient; (d) RMS error of individual
pulses (RMSstd)
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The quality assessment of the pulse wave shape revealed that the errors in the
Designed system were approximately three times higher than the errors of the
Sphygmocor system. The Standard deviation was very high in comparison,
which can be attributed to the signal fluctuations caused by poor measure-
ments. In the case of the systolic pressure, the error was much greater for
the designed system. This is seen by the error (2.3 ± 18.9 mmHg). In the
distribution shown in Figure 5.3(a) Systolic errors can be seen at extreme val-
ues of −40% and 30%. These extreme values contribute to the high standard
deviation. The rise time of the systolic peak proved to be consistent, with an
error of −0.87 ± 17.5 ms. This was better than the rise time of the Sphygmo-
cor system. These two measurements show that although the pulse varied in
height, the foot of the pulse was always measured accurately.
The variability of the pulse signal is measured by the RMS Error (RMSstd)
of the signal and can be seen in Figure 5.3(d). The average RMS error of
11.35 ± 18.9 mmHg is much greater than that of the Sphygmocor data (3.81
± 4.41 mmHg). Part of this high average is attributed to a poor pulse recording
from subject 8 (RMSstd = 134 mmHg). If the results from subject 8 were
omitted the RMS Error would be reduced to 6.92 ± 5.38 mmHg, which would
be more acceptable. Although the designed system showed a high variability,
the correlation coefficient was high (0.90 ± 0.09). The pressure pulse of test
subject 8 was difficult to record and as a result a poor pulse signal was captured.
Even with this large variation of subject 8, all of the test subjects results were
used for the comparison against the Sphygmocor.
5.5 Comparisons Against Sphygmocor
The results of the comparison are summarised in table 5.3, and are represented
as mean ± SD. Figure 5.4(a–f) shows the distribution of the pressure and time
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for the first and second systolic peak and the dicrotic notch. The distribution
of the RMS error is shown in Figure 5.4(g). The errors shown in Figure 5.4(b–
f) are the errors between the mean pulse measured from the designed system
and the mean pulse measured from the Sphygmocor system. Since the mean
pulse from both systems was calibrated to the systolic pressure measured from
the sphygmomanometer, the error in systolic pressure between the mean pulses
would be zero. Therefore Figure 5.4(a) shows the error between the individual
pulses, for each subject, from the designed system with the mean pulse meas-
ured from the Sphygmocor system.
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Figure 5.4: Results of comparison measurements: Percentage error of systolic
pressure (a) and time (b); Percentage error of dicrotic notch pressure (c) and
time (b); Percentage error of second systolic pressure (e) and time (f); (g)
distribution of RMS error
The pressure pulse measured from the designed system had a decrease in pres-
sure at the dicrotic notch (−1.1 ± 8.57 mmHg) and at the second systolic peak
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Diagnostic Pressure (mmHg) Time (msec)
Measurement Error % Error Error % Error
Systolic Peak 2.3 ± 18.9 1.3 ± 8.3 −1.9 ± 5.3 −2.4 ± 5.6
Dicrotic Notch −1.1 ± 8.57 −1.6 ± 8.1 −2.3 ± 13.8 −2.4 ± 7.4
2nd Systolic Peak −2.3 ± 4.4 −2.3 ± 4.5 −8.1 ± 36.2 −2.3 ± 9.7
RMS Error (mmHg) 9.99 ± 5.83
Table 5.3: Results of Sphygmocor comparison
(−2.3 ± 4.4 mmHg). In six of the test subjects the time to the dicrotic notch
and second systolic peak was shorter when measured with the designed system.
This can be seen in the systolic peak of the pulse shown in Figure 5.5. The
percentage errors for the time to the dicrotic notch (−2.4 ± 7.34 %) and the
second systolic peak (−2.3 ± 9.7 %) are similar. This constant error in time
can either be attributed to a change in pulse rate or a delay in the Sphygmocor
system. Although a change in pulse rate is not impossible, every subject’s pulse
rate would of needed to increase to provide the calculated time error. It can be
seen in Figure 5.5 that the waveform of the designed system exibits a quicker
decrease in pressure after the systolic peak in comparison to the Sphygmocor
waveform. As previously mentioned, the Sphygmocor systems incorporates
an algorithm to determine the transfer function of the arterial system. This
algorithm could create this small delay which is noticable in Figure 5.5.
The average systolic peak is greater in the designed system (2.3 ± 18.9 mmHg),
however, the distribution of the error shows the error evenly distributed around
zero. Since the system is calibrated to the blood pressure measured from the
sphygmomanometer, this difference can be attributed to the quality of the
pulse signal and not to distortion of the pulse by the measuring system.
Overall the pulse wave shape measured with the designed system was an ac-
curate representation of the Sphygmocor system. There was a time difference
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Figure 5.5: Comparison of the pulse between the two systems
between the two measurements. This error could be confirmed, in future stud-
ies, by comparing the designed system with other invasive and non-invasive
PWA systems. Since the Sphygmocor could not be guaranteed as a true re-
flection of the pulse, it cannot be said for certain whether the error was caused
by the designed system or the Sphygmocor system. This would need to be
confirmed by analysing a transfer function of the designed system.
5.6 Frequency Analysis
5.6.1 Frequency Spectrum
The frequency spectrum of the arterial systems, which was presented in Chapter 4
has the majority of the power dispersed below 5 Hz. The main frequency har-
monics of the arterial pulse, measured from both systems were located near
DC, 2 Hz, 3.5 Hz and 4 Hz. These harmonics fluctuated slightly between
the different test subjects, but the fluctuation was consistent in both systems.
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Figure 5.6: Magnified section of the frequency spectrum
The pulses measured from the designed system did not contain any additional
frequency components even though the sampling frequency of the designed
system was higher than that of the Sphygmocor.
The comparison of the normalised FFTs between the two systems revealed that
the ratio of power between the first harmonic and subsequent harmonics are
equal for both systems. This can be seen in the magnified frequency spectrum
shown in Figure 5.6. The did appear do be a small frequency shift in some of
the results, however this could be attributed to rounding errors.
5.6.2 Impulse Response
The impulse response was used to calculate the transfer function of the overall
system. The transfer function H(S) is defined as the output (Y (S)) divided
by the input (X(S)) in the frequency domain; H(S) = Y (S)
X(S)
. For an impulse,
X(S) equals 1 [38]. Therefore the transfer function of the designed system
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Figure 5.7: Transfer function of the designed system
was calculated by applying the FFT to the impulse response (y(t)) (Shown in
Figure 4.8).
The transfer function, which can be seen in Figure 5.7, clearly shows the
expected roll-off at 40Hz (due to the Butterworth LPF) and the roll-off before
0.3Hz (due to the High-Pass filter). Imperfections in the pass-band, and an
additional roll-off at 10Hz are also present. These are possibly the result of
a non ideal test set-up, the non linearities present in the pressure sensor, or
the error in capacitance due to the capacitors used in the Butterworth filter.
Higher frequency components (> 70Hz) were attenuated to between −150 and
−200 dB as expected.
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Chapter 6
Conclusion
6.1 Discussion
Hardware
The arterial tonometry system designed for this research was able to measure
and record the arterial pressure pulse. The signals recorded contained large
fluctuations and DC drift, which was due to flaws in the hardware design,
particularly the pressure probe. These large fluctuations resulted in the signal
being separated into individual pulses and only being able to compare the
average pulse of the signal.
The main focus on the hardware design was electrical safety. The system was
required to meet the IEC 601 safety standard. This ensured the patient’s
safety by isolating the system from any high voltages and breaking the ground
connection between the patient and high voltage equipment. The designed
system was based upon a battery power supply and incorporated electrical
isolation. Electrical safety was tested with the use of an IEC 601 testing
station, which tested leakage current and patient auxiliary current. The overall
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results revealed that the system fell well within the safety limits and was
acceptable for use on humans.
The hardware design was based on a low voltage single supply 5 Volt system.
All the components were chosen for their accuracy and precision. The design
did not make use of any components which were expensive or difficult to obtain.
The total component cost of the system amounted to less than R2000. Should
this design be taken further, the designer would not have any problems in
sourcing components.
The primary concern in the design was the pressure transducer. This, along
with the lack of experience of the operator (for the designed system), were the
main factors for recording poor signals. The transducer was too large for the
required application. In any further design a sensor with similar characteristics
but a smaller pressure diaphragm should be used. The design of the housing
for the sensor requires a lot more thought. A smaller, less clumsy housing,
which is easy to hold would be better suited for blood pressure measurements.
An experienced operator would be able to find the best pressure pulse and be
able to keep the transducer steady. This will result in the best quality signal
being recorded.
In this research the signal was sampled at 1kHz, where the Sphygmocor sys-
tem only sampled at 128Hz. The larger sampling frequency was chosen in an
attempt to find any other frequency components which may have been lost
by the lower sampling frequency of the Sphygmocor. A FFT of the signals
from both systems revealed that no extra frequency harmonics existed and
that the majority of the power was below 10Hz. These findings correspond to
the research by Fetics [36] and O’Rourke [19].
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Data Analysis
The signal was analysed by assessing the variability of the pulse (quality of
the pulse) and by comparing the average pulse wave shape measured from
both systems. The pulse variability yielded a standard deviation (RMS Error)
of 11.35 ± 18.9 mmHg, with a systolic pressure error of 2.3 ± 19.9 mmHg.
The cause of this error is attributed to the large clumsy sensor and operator
inexperience. In a larger group of test subjects and with more measurement
experience the RMS error could be reduced.
The pulse wave measured from the designed system contained the same com-
ponents and followed the same contour as that of the Sphygmocor system and
no data was lost from the pulse contour. The measurements from the de-
signed system showed errors in the time difference (−2.4 ± 7.34 %) and in
pressure (−1.1 ± 8.57 mmHg). The source of the error has been attributted
to difficiencies in the hardware design and inconsiatancies in the measurement
procedure.
The transfer function (H(s)) of the designed system was estimated in an at-
tempt to model the system. An analysis of the transfer function showed the
expected roll-off at the 0.3Hz and 40Hz, however the pass band was not very
flat.
6.2 Further Research
The scope of this research did not cover every aspect of pulse wave analysis.
This research could be extended to cover the following topics:
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Comparison with Invasive Arterial Measurements
Invasive measurements of the arterial pulse wave shape would provide the most
accurate data. Problems such as sensor position, DC drift and the reliability
of a steady hand to record the pressure would be eliminated. A comparison
between a direct arterial pressure measurements and non-invasive measure-
ments using the designed system would be required to identify the extent of
signal distortion caused by the designed system.
Aortic transfer function
Extensive research has been conducted in estimating the transfer function
between the aortic pulse and the radial pulse. O’Rourke [1, 19] has developed
a transfer function which is used in the Sphygmocor system. Other research
conducted by Millasseau et al [10], Segers et al [13] and Fetics et al [36] have
assessed the validity of the transfer function by estimating their own transfer
function and comparing the two.
Further research would involve performing intra-arterial pressure measure-
ments in a catheter laboratory. This could be used in the estimation of an
aortic transfer function and as a reference for a non-invasive pulse wave shape
comparison.
Hardware improvements
The designed measurement system produced accurate results in comparison to
the Sphygmocor system, however, it can be further improved. The pressure
sensor was the primary factor for inaccuracies and can be improved. The sensor
housing could be re-designed to be more comfortable to use. This would result
in improved readings, and greater accuracies in the pulse wave measurements.
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Once the hardware has been improved and finalised the viability of marketing
the system can be assessed.
6.3 Conclusion
Pulse wave analysis provides valuable information in the assessment of arterial
diseases. Measurements such as Augmentation index (AiX), wave reflection
and pulse wave velocity (PWV) relate to the health of the arteries and the
heart. To provide an accurate assessment of the condition of the arteries the
pulse wave shape needs to be carefully measured. Existing systems such as
the Sphygmocor PWA system provide accurate assessment of the arteries by
determining the AiX, and PWV. A system was designed to investigate the
design issues in a pulse wave analysis system. The system was tested and
validated with data from the Sphygmocor system.
The design of the system took the necessary precautions such as patient safety
and comfort into account. This was achieved through electrical isolation and
by maintaining a battery power supply. The system conformed to the required
IEC-601 safety standard, which ensured patient safety throughout the testing
procedure.
The hardware designed consisted of signal amplification and filtering circuitry.
The pulse signal was amplified from a small voltage of < 10mV to a range of
1–5V. The signal was modulated to a small degree, which was caused by the
response of the filters. This modulation did not introduce any large error and
the analysis was still successful. The system could be improved by a redesign
of the hardware, especially the pressure probe.
The data from the two systems were compared in both the time domain and the
frequency domain. In the time domain the error between the two systems was
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small and was considered acceptable. The frequency spectrum revealed that
the two systems produced the same harmonics and no additional information
was gained or lost from either system.
The performance of the design suggests that, in some respects, the design
was comparable to the commercial system, however, a number of performance
characteristics fell short of the commercial system. This leaves several options
for further research. The pressure probe should be redesigned for easier record-
ings. Research into the transfer function of the arterial system could follow on
from this research, however an improved hardware design is required first.
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Appendix A
Pulse Wave Analysis History
Sphygmography, the study of the arterial pulse, was started over 100 years
ago. William Bright identified high blood pressure as the hardness of the
pulse in his research in 1827. Frederick Akbar Mohamed, in 1872, illustrated
the importance of the arterial pulse wave shape with the use of graphical
methods [1, 19]. Mohamed established the foundation for pulse wave analysis
as well as developing one of the first graphical methods to record the arterial
pulse. He described the arterial pulse and identified the difference between the
radial and carotid pulse. He also showed the effect of high blood pressure on
the radial pulse
The technique to record the pulse wave was time consuming and difficult. The
wave shape was also difficult to characterise and was prone to artifact. The
introduction of the cuff sphygmomanometer, in the early 1900s, provided an
easy solution to these problems. The cuff, which was easier to use and more
accurate, produced numbers for the extreme points of the pulse. These could
simply be referenced to a measure of cardiac strength. This led to the decline
in interest in sphygmography [1, 19].
The study of the pulse wave shape attracted more interest and recognition
with the advancement of computers and highly accurate pressure transducers.
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Piezo-electric transducers, which were originally developed for intra-ocular
pressure were adapted to be used for arterial purposes. These are far more
accurate, reliable and easier to use than the original mechanical sphygmogram
developed by Mohamed [1]. This has led to a greater understanding of the
arterial system and better diagnosis of arterial diseases.
The analysis of the wave shape not only revealed systolic, diastolic and mean
pressures, it also provided an assessment of the wave reflection. Wave reflec-
tion changes with the different properties of the arteries, such as hardening of
arteries, and is described in Section 2.2.1. MacDonald of St Bartholomew’s
Hospital, London (1950s) was responsible for explaining the difference of aortic
waves and peripheral waves by explanation of wave reflection in arteries. He
introduced the transfer function to characterise properties of arteries in the
frequency domain. The work by Macdonald as well as J.R. Womersley and
Taylor, also from St Bartholomew’s Hospital, has led to most of the techniques
used for pulse wave analysis [1]
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Appendix B
Hardware Circuits Description
B.1 Pressure Sensor Circuit
The design uses the IC-Sensor model 84 (IC Sensor, MSI, USA). This is a
piezoresistive pressure sensor which uses laser trimmed resistors in a wheat-
stone bridge. The compensation resistor allows the sensor to be interchange-
able to within ± 1% of the amplifier output span when used with the correct
external resistors [28].
The model 84 transducer is excited by a constant current source between 1mA–
1.5mA. The circuit to provide the current is shown in Figure B.1. The current
source is controlled by the 1.235V reference diode and a 920Ω current set
resistor (R4) (1% tolerance). The current I0 is defined as I0 = (E0 − e0)/R4,
where E0 is the reference voltage and e0 is is the offset of the amplifier IC1D
(≈ 0). This configuration provides a current source of 1.343mA.
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Figure B.1: Excitation circuit for the pressure sensor
B.2 Amplification Circuits
B.2.1 Pressure Amplification
The amplification for the pressure sensor was achieved using an instrument-
ation amplifier. The design of the amplifier, as seen in Figure B.2, used 3
op-amps instead of a single chip instrumentation amp.
The op-amps used in the circuit are Microchip MCP609 amplifiers. This is
a quad packaged amplifier and its features include single supply operation,
250µV offset voltage, rail-to-rail output and a typical CMRR of 91 dB. The
gain of the amplifier is controlled by the gain set resistor incorporated in the
pressure sensor.
The differential input stage of the instrumentation amplifier has a gain of
Gain = 1 + (R1 + R2)/r, where r is the gain set resistor of the pressure trans-
ducer. The gain set resistor r is a laser trimmed resistor calibrated to provide
an output span of 2V when the excitation current is set to 0.996mA and the
feedback resistors R1 and R2 are 100kΩ [39].
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Figure B.2: Sensor amplification circuit
The instrumentation amplifier has an additional gain of R8/R5 resulting in the
overall gain given by Equation B.1. The resistor values are set to R5 = R6 = 200kΩ
and R7 = R8 = 500kΩ. The ratio A is between the actual excitation current
(1.343mA) and the reference current(0.996mA).
Vout = 2× A×R8/R5 = 2× (1.343/0996)× (500k/200k) = 6.74V (B.1)
The amplifier is supplied by 5V, therefore at full scale pressure (300mmHg)
saturation will occur. Since the full scale of the pressure sensor is not used,
this is not a concern.
The positive input of the differential amplifier has been biased with an ad-
ditional offset of 0.85V by the voltage divide R9 and R10. This offset was
introduced to overcome the forward voltage drop of the Infrared emitting di-
ode in the optocoupler.
89
B.2.2 ECG Amplification Circuit
The ECG instrumentation amplifier and right leg drive circuit is shown in
Figure B.3. The amplification of the instrumentation amplifier is calculated
using Equation B.2 [40]. Resistor RG is the gain set resistor R1‖(R2 + R3) =
4.4kΩ. The gain of the instrumentation amplifier is calculated to be 23.2.
VO =
(
1 +
100kΩ
RG
)
VC (B.2)
Figure B.3: ECG amplifier and right leg drive circuit
The right leg amplifies the common mode voltage at the junction of R2 and
R3 through an inverting amplifier. The output of the amplifier is used as a
reference electrode for the differential measurement. The right leg driver re-
duces the common mode interference of the differential inputs. Capacitor C2
is chosen to maintain the stability of the right leg drive by reducing oscilla-
tions [22, 29].
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Vin
Vout
Figure B.4: Fourth order Butterworth filter used for signal conditioning
B.3 Filter Circuits
The low pass Butterworth filter as used in the arterial tonometry circuit is
shown in Figure B.4. The LPF is a 4th order filter with a cutoff frequency
of 40Hz and unity gain. The component values were chosen according to a
sample filter design in Microchip FilterLab.
The filter, as show in figure B.5, attenuates the ECG signal to a range of 0.05–
100Hz. The high pass filter is a passive filter with a unity gain and a cutoff
Vin
Vout
Figure B.5: First order bandpass filter
frequency of approximately 0.05Hz, as calculated in Equation B.3.
fc(hpf) = 1/2piR7C3 = 1/2(pi)(3.3MΩ)(1uF ) = 0.048Hz (B.3)
The low pass filter has a gain of 40 with a cut off frequency of approximately
100Hz as calculated in Equation B.4.
fc(lpf) = 1/2piR6C4 = 1/2(pi)(4.7kΩ)(0.33uF ) = 102.6Hz (B.4)
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A Twin-T notch filter is used to attenuate the 50Hz line interference. The
passive filter, which is shown in Figure B.6 comprises a first order high pass
and first order low pass filter whose frequencies are exactly matched to the
cutoff frequency of fc = 1/2piRC. The capacitor values are all set equal; i.e.
C = C13 = C14 = C15 = C16 = 4.7nF and the same applies to the resistor
values; i.e. R = R21 = R22 = R23 = R24 = 680kΩ. By using matched values
for R and C a cutoff frequency of fc = 49.8Hz is achieved. The op-amps, IC3A
and IC3B and variable resistor R27 provide a tuning method to improve the
notch characteristic at the notch frequency [41].
Figure B.6: Twin-T notch filter circuit diagram
B.4 Isolation Circuit
The electrical isolation circuit is shown in Figure B.7. The design uses the
4N28 optocoupler, which comprises a photo-transistor optically coupled to an
infrared emitting diode. The unit is packaged in a 6-pin plastic dual-inline
package. Resistor R10 and R13 limit the forward current of the emitter to
below 10mA. The emitter current of the transistor is limited to below 10mA
by resistors R14 and R15.
The infrared emitting diode has a forward voltage of 1.25V [33]. In practice
the forward voltage was measured to be 0.9V. In the arterial tonometry system
a voltage offset of 0.85V was added to the positive pin of the Instrumentation
amplifier to overcome the forward voltage. There was no need to add an offset
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Vin
Vout
Isolation
Barrier
Figure B.7: Isolation circuit using an optocoupler
to the ECG circuit since the ECG signal was referenced at 2.5V. However,
output voltage of the ECG amplifier had a range of 0–4.6V, referenced at
0.6V. This did not cause any loss of signal.
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B.5 Circuit Diagrams
Figure B.8: Schematic of main circuit board
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Figure B.9: Schematic of sensor unit circuit
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Appendix C
Measured Data and Results
C.1 Recorded Data
The results for all test subjects are shown in Figures C.1 (a–f) to Figures C.8 (a–
f). The signals measured using the designed system and the Sphygmocor sys-
tem are shown in Figures C.1 – C.8(a) and (b) respectively. The pulses are
separated into individual periods using the maximum second derivative method
(Figures C.1 – C.8 (c & d)). The Mean ± Standard Deviation of the meas-
ured pulse from the designed system is shown in Figures C.1 – C.8(e) and a
comparison of the mean pulse of both systems is shown in Figures C.1–C.8 (f).
The signals recorded using the designed system contained a lot more variation
from the signals recorded using the Sphygmocor system. DC drift can be seen
in the signals from both the designed system and Sphygmocor system, which
was caused by movement of the pressure probe. In the case where the arterial
pulse was difficult to find the quality of the recorded waveforms were poor
(Figures C.1, C.6 and C.8)
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Figure C.1: Measured results of subject 1: (a) pulse signal measured using
designed System; (b) pulse signal measured using Sphygmocor system; (c)
separated pulse from designed system; (d) separated pulse from Sphygmocor
system; (e) Mean (solid line) and standard deviation (dashed line) of pulse
from designed system; (f) comparison of pulse of the designed system and the
Sphygmocor system
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Figure C.2: Measured results of subject 3: (a) pulse signal measured using
designed System; (b) pulse signal measured using Sphygmocor system; (c)
separated pulse from designed system; (d) separated pulse from Sphygmocor
system; (e) Mean (solid line) and standard deviation (dashed line) of pulse
from designed system; (f) comparison of pulse of the designed system and the
Sphygmocor system
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Figure C.3: Measured results of subject 4: (a) pulse signal measured using
designed System; (b) pulse signal measured using Sphygmocor system; (c)
separated pulse from designed system; (d) separated pulse from Sphygmocor
system; (e) Mean (solid line) and standard deviation (dashed line) of pulse
from designed system; (f) comparison of pulse of the designed system and the
Sphygmocor system
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Figure C.4: Measured results of subject 5: (a) pulse signal measured using
designed System; (b) pulse signal measured using Sphygmocor system; (c)
separated pulse from designed system; (d) separated pulse from Sphygmocor
system; (e) Mean (solid line) and standard deviation (dashed line) of pulse
from designed system; (f) comparison of pulse of the designed system and the
Sphygmocor system
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Figure C.5: Measured results of subject 6: (a) pulse signal measured using
designed System; (b) pulse signal measured using Sphygmocor system; (c)
separated pulse from designed system; (d) separated pulse from Sphygmocor
system; (e) Mean (solid line) and standard deviation (dashed line) of pulse
from designed system; (f) comparison of pulse of the designed system and the
Sphygmocor system
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Figure C.6: Measured results of subject 7: (a) pulse signal measured using
designed System; (b) pulse signal measured using Sphygmocor system; (c)
separated pulse from designed system; (d) separated pulse from Sphygmocor
system; (e) Mean (solid line) and standard deviation (dashed line) of pulse
from designed system; (f) comparison of pulse of the designed system and the
Sphygmocor system
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Figure C.7: Measured results of subject 8: (a) pulse signal measured using
designed System; (b) pulse signal measured using Sphygmocor system; (c)
separated pulse from designed system; (d) separated pulse from Sphygmocor
system; (e) Mean (solid line) and standard deviation (dashed line) of pulse
from designed system; (f) comparison of pulse of the designed system and the
Sphygmocor system
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Figure C.8: Measured results of subject 9: (a) pulse signal measured using
designed System; (b) pulse signal measured using Sphygmocor system; (c)
separated pulse from designed system; (d) separated pulse from Sphygmocor
system; (e) Mean (solid line) and standard deviation (dashed line) of pulse
from designed system; (f) comparison of pulse of the designed system and the
Sphygmocor system
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C.2 Results of Pulse Foot Calculation
Tables C.1–C.3 present the results of the three methods used to determine
the foot of the pulse wave. Table C.1 compares the correlation coefficient,
Table C.2 compares the time difference of the systolic peak and Table C.3
compares the RMS Error between the individual pulses. In each table the
comparison is made between the designed system and the Sphygmocor system
for Methods 1 and 2. Method 3 was only applied to the designed system as
no ECG was recorded for the Sphygmocor data, however, the results are still
presented.
No. Correlation Coefficient (Mean ± S.D.)
Method 1 Method 2 Method 3
DS SPH DS SPH DS
1 0.84 ± 0.04 0.98 ± 0.004 0.87 ± 0.03 0.99 ± 0.003 0.85 ± 0.03
3 0.85 ± 0.06 0.99 ± 0.001 0.96 ± 0.01 0.99 ± 0.001 0.96 ± 0.01
4 0.92 ± 0.02 0.98 ± 0.002 0.96 ± 0.01 0.99 ± 0.002 0.96 ± 0.01
5 0.94 ± 0.02 0.99 ± 0.002 0.98 ± 0.01 NR NR
6 0.92 ± 0.04 0.99 ± 0.004 0.95 ± 0.02 0.99 ± 0.004 0.94 ± 0.04
7 0.91 ± 0.04 0.98 ± 0.006 0.95 ± 0.01 0.98 ± 0.006 0.79 ± 0.02
8 0.94 ± 0.01 0.99 ± 0.005 0.90 ± 0.04 0.99 ± 0.004 0.93 ± 0.01
9 NR NR 0.74 ± 0.09 0.99 ± 0.003 0.77 ± 0.06
Mean 0.90 0.99 0.90 0.99 0.86
SD 0.05 0.01 0.09 0.01 0.16
NR = No Result, DS = Designed system, SPH = Sphygmocor system
Table C.1: Comparison of correlation coefficient.
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No. Systolic Time Delay (τ)(msec) (Mean ± S.D.)
Method 1 Method 2 Method 3
DS SPH DS SPH DS
1 −10 ± 31 −4.7 ± 6.6 5.2 ± 21 0.78 ± 5.76 3.0 ± 20
3 −7.6 ± 21 −0.7 ± 2.4 −0.86 ± 4.2 −2.8 ± 3.95 0.64 ± 6.23
4 0.28 ± 16.8 −4.4 ± 4.17 −0.6 ± 8.67 −1.11 ± 2.95 0.42 ± 7.56
5 −0.69 ± 13.7 −4.26 ± 4.08 −1.14 ± 7.20 NR NR
6 5.2 ± 20.2 −0.86 ± 4.69 −0.11 ± 5.96 −4.34 ± 4.11 -0.11 ± 6.82
7 −1.28 ± 18.4 2.60 ± 6.37 −1.0 ± 10.51 NR NR
8 25.4 ± 20.5 −2.9 ± 5.81 −17.8 ± 27.3 −1.95 ± 6.92 −9.63 ± 15.36
9 NR NR 6.7 ± 25.8 −1.74 ± 7.41 6.0 ± 21.2
Mean −5.36 −2.30 −0.87 −1.92 −0.67
SD 22.05 5.23 17.50 5.40 14.65
NR = No Result, DS = Designed system, SPH = Sphygmocor system
Table C.2: Comparison of time variation of the systolic peak.
No. RMS Error (mmHg) (Mean ± S.D.)
Method 1 Method 2 Method 3
DS SPH DS SPH DS
1 10.7± 2.77 3.9 ± 1.47 12.1 ± 4.5 3.9 ± 1.9 13.3 ± 4.44
3 5.37± 1.73 1.06± 0.48 4.07± 1.97 1.43 ± 0.72 11.72 ± 2.61
4 4.25 ± 1.84 2.26± 1.05 4.61± 0.62 2.76 ± 1.76 10.33 ± 1.64
5 4.08 ± 1.15 1.36 ± 0.65 3.02 ± 1.31 NR NR
6 4.74 ± 3.41 1.81 ± 0.47 3.40 ± 1.10 2.18 ± 0.56 4.95 ± 1.86
7 6.85 ± 1.85 2.38 ± 0.37 6.67 ± 4.36 2.69 ± 0.42 35.83 ± 5.95
8 18.73 ± 9.17 10.20 ± 6.55 45.55 ± 42.21 12.65 ± 7.9 28.8 ± 9.43
9 NR NR 12.82 ± 6.90 2.50 ± 1.15 14.75 ± 7.75
Mean 7.50 3.11 11.35 3.80 18.01
SD 6.02 3.60 18.9 4.41 15.98
NR = No Result, DS = Designed system, SPH = Sphygmocor system
Table C.3: Comparison of RMS error between individual pulses.
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C.3 Results of Time Analysis
The designed system and the Sphygmocor system were compared by analys-
ising the differences in the systolic peak, the dicrotic notch and the second
systolic peak. The results of these comparisons are presented in Tables C.4 –
C.11.
Table C.4 and Table C.5 compare the systolic blood pressure error for the
designed system and the Sphygmocor system respectively. The error is the
difference between the mean blood pressure as calculated by the calibration
algorithm and the blood pressure measured with cuff sphygmomanometer.
No. Measured SBP Mean SBP Error % Error
(mmHg) (mmHg) (mmHg) ( %)
1 130 132.9 ± 7.8 2.94 ±7.88 2.26 ± 6.07
3 134 134.7 ± 2.7 0.74 ± 2.7 0.55 ± 2.0
4 130 130.6 ± 3.1 0.6 ± 3.1 0.45 ± 2.4
5 120 120.3 ± 3.4 0.3 ± 3.4 0.25 ± 2.86
6 118 118.2 ± 3.3 0.2 ± 3.3 0.001 ± 0.03
7 124 124.8 ± 8.3 0.9 ± 8.3 0.7 ± 6.7
8 250 262.5 ± 58.2 12.5 ± 58.2 5.0 ± 23.3
9 114 115.8 ± 6.6 1.8 ± 6.6 1.6 ± 5.7
Mean 140 139.9 2.3 1.3
SD 44.9 47.6 18.9 8.3
Table C.4: Comparison of systolic pressure measured from designed system
No. Measured SBP Mean SBP Error % Error
(mmHg) (mmHg) (mmHg) ( %)
1 130 130.1 ± 6.18 −0.15 ±6.18 −0.11 ± 4.75
3 134 134.1 ± 1.8 0.11 ± 1.8 0.08 ± 1.34
4 130 129.9 ± 4.7 0.03 ± 4.7 0.02 ± 3.62
5 120 120.1 ± 1.9 0.06 ± 1.9 0.05 ± 1.60
6 118 118.0 ± 3.7 0.02 ± 3.7 0.00 ± 0.03
7 124 125.9 ± 1.5 1.89 ± 1.5 1.52 ± 1.19
8 250 250.3 ± 19.2 0.32 ± 19.2 0.13 ± 7.68
9 114 113.9 ± 3.5 −0.02 ± 3.5 −0.02 ± 3.06
Mean 140 138.9 0.10 0.07
SD 44.9 41.6 6.67 3.36
Table C.5: Comparison of systolic pressure measured from sphygmocor system
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Table C.6 compares the systolic rise time between the two systems. The error
is calculated from the mean of the pulse for each subject.
No. DS SPH Error % Error
(ms) (ms) (ms) ( %)
1 92 96 −4.0 −4.2
3 75 84 −9.0 −10.7
4 78 95 −17.0 17.9
5 112 104 8.0 7.7
6 85 86 −1.0 −1.2
7 78 81 −3.0 −3.7
8 105 103 2.0 1.9
9 96 97 −1.0 −1.0
Mean 90.1 92 −1.9 −2.4
SD 13.6 9.1 5.3 5.6
DS = Designed system, SPH = Sphygmocor system
Table C.6: Comparison of rise time of the systolic peak
Table C.7 and C.8 compare the pressure and timing of the dicrotic notch
between the two systems for each subject.
No. DS SPH Error % Error
(ms) (ms) (ms) ( %)
1 274 285 −11.0 −3.9
3 246 252 −6.0 −2.4
4 267 285 −18.0 −17.9
5 288 296 −8.0 −2.7
6 306 299 7.0 2.3
7 308 306 2.0 0.7
8 278 288 −10.0 −3.5
9 350 324 26.0 8.0
Mean 289.6 291.88 −2.3 −2.4
SD 31.7 20.7 13.8 7.4
DS = Designed system, SPH = Sphygmocor system
Table C.7: Comparison of time to the dicrotic notch
Table C.9 and C.10 compare the pressure and timing of the second systolic
peak between the two systems for each subject.
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No. DS SPH Error % Error
(mmHg) (mmHg) (mmHg) ( %)
1 101 93 8.0 8.6
3 96 99 −3.0 −3.0
4 90 98 −8.0 −8.2
5 85 86 −1.0 −1.2
6 90 95 −5.0 −5.3
7 96 100 −4.0 −4.0
8 137 122 15.0 12.3
9 84 95 −11.0 −11.6
Mean 97.4 98.5 −1.1 −1.6
SD 17.0 10.5 8.57 8.1
DS = Designed system, SPH = Sphygmocor system
Table C.8: Comparison of dicrotic notch value
No. DS SPH Error % Error
(mmHg) (mmHg) (mmHg) ( %)
1 101 97 4.0 4.1
3 104 103 1.0 0.9
4 105 108 −3.0 −2.8
5 88 89 −1.0 −1.1
6 93 97 −4.0 −4.1
7 99 102 −3.0 −2.9
8 153 155 −2.0 −1.3
9 85 96 −11.0 −11.5
Mean 103.5 105.9 −2.3 −2.3
SD 21.3 20.6 4.4 4.5
DS = Designed system, SPH = Sphygmocor system
Table C.9: Comparison of second systolic peak
No. DS SPH Error % Error
(ms) (ms) (ms) ( %)
1 296 356 −60.0 −16.9
3 312 321 −9.0 −2.8
4 373 397 −24.0 −6.0
5 451 393 58.0 14.8
6 373 371 2.0 0.5
7 352 376 −24.0 −6.4
8 359 390 −31.0 −7.9
9 376 353 23.0 6.5
Mean 361.5 369.6 −8.1 −2.3
SD 46.8 25.6 36.2 9.7
DS = Designed system, SPH = Sphygmocor system
Table C.10: Comparison of time to second systolic peak
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Table C.11 presents the RMS Error between the designed system and th
Sphygmocor system. The error is calculated from the average pulse for each
subject.
No. RMS Error
(mmHg)
1 5.55
3 6.16
4 9.54
5 13.50
6 5.04
7 8.34
8 22.77
9 9.08
Mean 9.99
SD 5.83
Table C.11: Comparison of Root-Mean-Square (RMS) errors
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C.4 Frequency Spectrum Results
The frequency spectrum for subjects 1–9 are illustrated in Figures C.9–C.16.
Figures C.9–C.16 (a) present the spectrum for the designed system, Figures C.9–
C.16 (b) present the spectrum for the Sphygmocor system and Figures C.9–
C.16 (c) compares the spectrum of the two systems.
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Figure C.9: Frequency spectrum of subject 1: (a) Frequency spectrum of
the designed system; (b) Frequency spectrum of the Sphygmocor system; (c)
Comparison of the frequency spectrum between two systems
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Figure C.10: Frequency spectrum of subject 3: (a) Frequency spectrum of
the designed system; (b) Frequency spectrum of the Sphygmocor system; (c)
Comparison of the frequency spectrum between two systems
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Figure C.11: Frequency spectrum of subject 4: (a) Frequency spectrum of
the designed system; (b) Frequency spectrum of the Sphygmocor system; (c)
Comparison of the frequency spectrum between two systems
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Figure C.12: Frequency spectrum of subject 5: (a) Frequency spectrum of
the designed system; (b) Frequency spectrum of the Sphygmocor system; (c)
Comparison of the frequency spectrum between two systems
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Figure C.13: Frequency spectrum of subject 6: (a) Frequency spectrum of
the designed system; (b) Frequency spectrum of the Sphygmocor system; (c)
Comparison of the frequency spectrum between two systems
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Figure C.14: Frequency spectrum of subject 7: (a) Frequency spectrum of
the designed system; (b) Frequency spectrum of the Sphygmocor system; (c)
Comparison of the frequency spectrum between two systems
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Figure C.15: Frequency spectrum of subject 8: (a) Frequency spectrum of
the designed system; (b) Frequency spectrum of the Sphygmocor system; (c)
Comparison of the frequency spectrum between two systems
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Figure C.16: Frequency spectrum of subject 9: (a) Frequency spectrum of
the designed system; (b) Frequency spectrum of the Sphygmocor system; (c)
Comparison of the frequency spectrum between two systems
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Appendix D
IEC Test Results
The printouts of the IEC 601-1 tests are included below.
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Appendix E
Ethics Approval
The clearance certificate from the human research ethics committee is attached
to this appendix.
116
117
References
[1] O’Rourke, M.F., Pauca, A., Jiang, X., “Pulse wave analysis,” Research
methods in human cardiovascular pharmacology, vol. 51, pp. 507–522,
2001.
[2] Karamanoglu, M. and Feneley, M. P., “On-line synthesis of the human as-
cending aortic pressure pulse from the finger pulse,” Hypertension, vol. 30,
pp. 1416–1424, 1997.
[3] van Lieshout, J.J., Toska, K., van Lieshout, E.J., Eriksen, M., Walloe,
L., Wesseling, K.H., “Beat-to-beat noninvasive stroke volume from ar-
terial pressure and doppler ultrasound,” European Journal of Applied
Physiology, vol. 90, pp. 131–137, 2003.
[4] Oliver, J.J. and Webb, D.J., “Noninvasive assessment of arterial stiff-
ness and risk of atherosclerotic events,” Arteriosclerosis, Thrombosis, and
Vascular Biology, vol. 23, pp. 554–566, 2003.
[5] Brinton, T.J., Cotter, B., Kailasam, M.T., Brown, D.L., Chio, S.,
O’Conner, D.T., DeMaria, A.N., “Development and validation of a non-
invasive method to determine arterial pressure and vascular compliance,”
The American Journal of Cardiology, vol. 80, pp. 323–330, 1997.
[6] Cruickshank, K., Rista, L., Anderson, S.G., Wright, J.S., Dunn, G., Gos-
ling, R.G., “Aortic pulse-wave velocity and it’s relationship to mortality
118
in diabetes and glocose intolerance.” Circulation, vol. 106, no. 16, p. 2085,
2002.
[7] Hlimonenko, I., Meigas, K., Vahisalu, R., “Waveform analysis of peri-
pheral pulse wave detected in the fingertip with photoplthysmograph,”
Measurement Science Review, vol. 3, pp. 49–52, 2003.
[8] Wilkinson, I.B., Fuchs,S.A., Jansen, I.M., Spratt, J.C., Murray, G.D.,
Cockcroft, J.R. and Webb, D.J., “Reproducibilty of pulse wave velocity
and augmentation index measured by pulse wave analysis,” Journal of
Hypertension, vol. 16, pp. 2079–2084, 1998.
[9] Weber, T., Auer, J., O’Rouke, M., Kvas, E., Lassig, E., Berent, R., Eber,
B., “Arterial stiffness, wave reflections, and the risk of coronary artery
disease,” Circulation, vol. 109, pp. 184–189, 2004.
[10] Millasseau,S.C., Patel,S.J., Redwood,S.R., Ritter,J.M., Chow-
ienczyk,P.J., “Pressure wave reflection assessed from the peripheral
pulse: Is a transfer function necessary?” Hypertension, vol. 41, pp.
1016–1020, 2003.
[11] Savage, M.T., Ferro, C.J., Pinder, S.J., Tomson, C.R.V., “Reproducib-
ility of derived central arterial waveforms in patients with chronic renal
failure,” Clinical Science, vol. 103, pp. 59–65, 2002.
[12] Wilkinson, I.B., Hall, I.R., MacCullum, H., Mackenzie, I.S., McEniery,
C.M., van der Arend, B.J., Shu, Y., Mackay, L.S., Webb, D.J., Cockcroft,
J.R., “Pulse Wave Analysis: Clinical evaluation of a noninvasive, widely
applicable method for assessing endothelial function,” Arteriosclerosis,
Thrombosis, and Vascular Biology, vol. 22, pp. 147–152, 2002.
119
[13] Segers, P., Carlier, S., Pasquet, A., Rabben, S.I., Hellevik, L.R., Remme,
E., de Backer, T., de Sutter, J., Thomas, J.D., Verdonck, P., “Individu-
alizing the aorto-radial pressure transfer function: feasibility of a model
based approach,” American Journal of Physiology - Heart and Ciculartory
Physiology, vol. 279, pp. H542–H549, 2000.
[14] McLeod, A.L., Uren, N.G., Wilkinson, I.B., Webb, D.J., Maxwell, S.R.J.,
Northridge, D.B., Newby, D.E., “Non-invasive measures of pulse wave
velocity correlate with coronary arterial plaque in humans,” Journal of
Hypertension, vol. 22, no. 2, pp. 363–368, 2004.
[15] Lemogoum, D., Flores, G., Van den Abeele, W., Ciarka, A., Leeman, M.,
Degaute, J. P., van de Borne, P., Van Bortel, L., “Validity of pulse pressure
and augmentation index as surrogate measures of arterial stiffness during
beta-adrenergic stimulation,” Journal of Hypertension, vol. 22, no. 3, pp.
511–517, 2004.
[16] Asmar, R., Benetos, A., Topouchian, J., Laurent, P., Pannier, B., Brisac,
A., Target, R., Levy, B.I., “Assessment of arterial distensibility by auto-
matic pulse wave velocity measurement,” Hypertension, vol. 26, no. 3, pp.
485–490, 1995.
[17] Steiner, L.A., Johnston, A.J., Salvador,R., Crozsnyka, M., Menon, D.K.,
“Validation of a tonomertric noninvasive arterial blood pressure monitor
in the intensive care setting,” Anaesthesia, vol. 58, pp. 448–454, 2003.
[18] The South African Bureau of Standards, “SABS IEC 60601-1, Medical
electrical equipment, Part 1: General requirements for safety,” The South
African Bureau of Standards, Tech. Rep., 1988.
[19] O’Rourke, M.F. and Gallagher, D.E., “Pulse wave analysis,” Journal of
Hypertension, vol. 14 (suppl 5), pp. S147–S157, 1996.
120
[20] Meyer, B.J. Meij, H.S. Meyer, A.C., HUMAN PHYSIOLOGY, 2nd ed.
Juta & Co, Ltd, 1997.
[21] Izzo, J.l. and Shykoff, B.E., “Arterial stiffness: Clinical relevance, meas-
urement, and treatment,” Reviews in Cardiovascular Medicine, vol. 2,
no. 1, pp. 29–40, 2001.
[22] Bronzino,J.D., THE BIOMEDICAL ENGINEERING HANDBOOK,
2nd ed. CRC Press, 2000, vol. 1.
[23] Davies,J.I. and Struthers, A.D., “Pulse wave analysis and pulse wave ve-
locity: a critical review of their strengths and weaknesses,” Journal of
Hypertension, vol. 21, pp. 463–472, 2003.
[24] O’Rourke, M.F., Avolio, A., Qasem, A., “Clinical assessment of wave
reflection,” Hypertension, vol. 42, no. 5, pp. e15–e16, Nov 2003.
[25] Salter, G.D., Bird, E., “Evaluation of arterial stiffness by measurement of
pulse wave velocity (PWV),” University of the Witwatersrand, Johannes-
burg, Tech. Rep., October 2002, Project report.
[26] McLaughlin, J., McMeill, M., Braun, B., McCormack, P.D., “Piezoelec-
tric sensor determination of arterial pulse wave velocity,” Physiological
Measurement, vol. 24, pp. 693–702, 2003.
[27] van Brakel, A., Swart, P.L., Chtcherbakov, A.A., Shlyagin, M.G., “Blood
pressure manometer using a twin Bragg grating Fabry-Perot interfero-
meter,” Photonics Asia, Beijing, China, 8-12 Nov 2004, Proceedings of
SPIE, vol. 5634, no. 86, November 2004.
[28] ICSensors, “Data Sheet model 84,” April 2000.
[29] Analog Devices, “AD620 Low cost, Low power, instrumentation ampli-
fier,” Analog Devices,Inc.,” Data Sheet, 1999.
121
[30] Texas Instruments, “Information for medical applications,” Texas Instru-
ments,” Application note, 2004.
[31] Stapletin, H. and O’Grady, A., “Isolation techniques for high-resolution
data-acquisition systems,” EDN Magazine (www.ednmag.com), pp. 113–
118, February 2004.
[32] Hewlett Packard, “High CMR Isolation Amplifer,” Hewlett Packard,”
Data sheet.
[33] Fairchild semiconductor, “General purpose 6-pin phototransistor opto-
couplers,” Fairchild Semiconductor Corporation,” Data sheet, 2003.
[34] J. Bentley, PRINCIPLES OF MEASUREMENT SYSTEMS, 3rd ed.
Pearson Education Limited, 1995.
[35] Chiu, Y.C., Arand, P.W., Schroff, S.G., Feldman, T., Carroll, J.D.,
“Determination of pulse wave velocities with computerised algorithms,”
American Heart Journal, vol. 121, no. 5, pp. 1460–1469, 1991.
[36] Fetics, B., Nevo, E., Chen, C., Hass, D.A., “Parametric model derivation
of transfer function for noninvasive estimation of aortic pressure by radial
tonometry,” IEEE Transactions on Biomedical Engineering, vol. 46, no. 6,
pp. 698–706, 1999.
[37] Cooper, G.R., McGillem, C.D., PROBABILISTIC METHODS OF SIG-
NAL AND SYSTEM ANALYSIS, 1st ed. Oxford University Press, 1999.
[38] Bruce, E.N., BIOMEDICAL SIGNAL PROCESSING AND SIGNAL
MODELLING, 1st ed. John Wiley and Sons, Inc., 2001.
[39] IC Sensors, Markell ,K., “A simple pressure sensor signal conditioning
circuit,” August 1999, Application note.
122
[40] Analog Devices, “AD623 Single supply, rail-to-rail, low cost instrumenta-
tion amplifier,” Analog Devices,Inc.,” Data Sheet, 1999.
[41] Horowitz, P. and Hill, W., THE ART OF ELECTRONICS, 2nd ed. Cam-
bridge University Press, 1989.
123
